<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-06-01</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OgXlyjh3z">ä»Šå¤©Lancet HIVå‘è¡¨äº†ä¸€é¡¹ååˆ†é‡è¦çš„HIVæ²»æ„ˆå‰ç»æ€§ä¸´åºŠè¯•éªŒã€‚è¿™é¡¹ç ”ç©¶éå¸¸é‡è¦ï¼Œå®ƒæŠ¥é“äº†é€šè¿‡é€ è¡€å¹²ç»†èƒç§»æ¤ï¼ˆHSCTï¼‰æ²»æ„ˆHIVä¸´åºŠé˜Ÿåˆ—IciStemä¸­æ‚£è€…ç—…æ¯’å­¦æ ‡è®°ç‰©...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ogxlyjh3z/">
    
    
    
    
    
      
    
    ä»Šå¤©Lancet HIVå‘è¡¨äº†ä¸€é¡¹ååˆ†é‡è¦çš„HIVæ²»æ„ˆå‰ç»æ€§ä¸´åºŠè¯•éªŒã€‚è¿™é¡¹ç ”ç©¶éå¸¸é‡è¦ï¼Œå®ƒæŠ¥é“äº†é€šè¿‡é€ è¡€å¹²ç»†èƒç§»æ¤ï¼ˆHSCTï¼‰æ²»æ„ˆHIVä¸´åºŠé˜Ÿåˆ—IciStemä¸­æ‚£è€…ç—…æ¯’å­¦æ ‡è®°ç‰©ï¼ˆbiomarkerï¼‰å˜åŒ–ã€‚ç›®å‰5ä¾‹HIVæ²»æ„ˆç—…ä¾‹å…¨éƒ¨æ˜¯é€šè¿‡HSCTå®ç°çš„ï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½‘é¡µé“¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼‰ï¼Œè€ŒHSCTæ²»æ„ˆHIVæœ‰4ä¸ªæœºåˆ¶ï¼Œè¿™ä¹Ÿæ˜¯æˆ‘åå¤å¼ºè°ƒçš„ï¼š1.  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/OgWL3b8wh">[æ†§æ†¬][æ†§æ†¬][æ†§æ†¬] [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-ogwl3b8wh/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1655755343/OgXPkiVSZ">å°±å¾ˆå–œæ¬¢è¿™äº›å¥‡å¥‡æ€ªæ€ªå¤§å„¿ç«¥ï¼Œä»¥åŠå¥³å¨²éƒ½è¡¥ä¸äº†çš„å¤§è„‘æ´[ç¬‘cry] - è½¬å‘ @å¼ æ€¡å¾®:&amp;ensp;ğŸª·ğŸª·ğŸª· [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1655755343-ogxpkivsz/">
    
    
    
    
    
      
    
    å°±å¾ˆå–œæ¬¢è¿™äº›å¥‡å¥‡æ€ªæ€ªå¤§å„¿ç«¥ï¼Œä»¥åŠå¥³å¨²éƒ½è¡¥ä¸äº†çš„å¤§è„‘æ´<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å¼ æ€¡å¾®<!-- raw HTML omitted -->:â€‚ğŸª·ğŸª·ğŸª· <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1655755343/Oh1j4zxzL">èŠå¾—å¾ˆå¼€å¿ƒï¼Œä¸”æœ€åå¤§å®¶çœ‹è¿‡çš„æ•…äº‹éƒ½è¿æˆä¸€ç‰‡ã€‚æ²ˆç‘æ¬£è¯´ï¼ŒåŸæ¥ã€Šåç¿¼å¼ƒå…µã€‹ä¸­è´ä¸æ¯æ¬¡èµ›å‰æœç”¨çš„ç»¿è‰²å°è¯ä¸¸å°±æ˜¯äºšç‘ŸÂ·è¨å…‹å‹’æ—©å¹´ç»æ‰‹çš„åˆ©çœ å®ã€‚ã€Šç–¼ç—›å¸å›½ã€‹ä¸­æ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1655755343-oh1j4zxzl/">
    
    
    
    
    
      
    
    èŠå¾—å¾ˆå¼€å¿ƒï¼Œä¸”æœ€åå¤§å®¶çœ‹è¿‡çš„æ•…äº‹éƒ½è¿æˆä¸€ç‰‡ã€‚æ²ˆç‘æ¬£è¯´ï¼ŒåŸæ¥ã€Šåç¿¼å¼ƒå…µã€‹ä¸­è´ä¸æ¯æ¬¡èµ›å‰æœç”¨çš„ç»¿è‰²å°è¯ä¸¸å°±æ˜¯äºšç‘ŸÂ·è¨å…‹å‹’æ—©å¹´ç»æ‰‹çš„åˆ©çœ å®ã€‚ã€Šç–¼ç—›å¸å›½ã€‹ä¸­æåˆ°çš„ã€Šæ¢¦ç˜¾ã€‹ã€ã€Šæ­¢ç—›æ¯’ä¸¸ã€‹ä¹Ÿéƒ½å¼•è¿›å‡ºç‰ˆäº†ï¼Œä¸å‰§é›†ã€Šæˆç˜¾è®¡é‡ã€‹ã€ã€Šæ— ç—›æ€æ‰‹ã€‹ã€çºªå½•ç‰‡ã€Šè¯å‰‚å¸ˆã€‹ã€ã€Šæ‰€æœ‰çš„ç¾ä¸½ä¸è¡€æ³ªã€‹å¯¹è¯»ï¼Œå¯çœ‹åˆ°éè™š <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/62b0d24fly1hqa64haybuj20u014016v.jpg%22">https://tvax1.sinaimg.cn/large/62b0d24fly1hqa64haybuj20u014016v.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh3DKz9GN">ğŸ”»è¿™ä¸æ˜¯çœŸæ­£çš„çƒè¿·ã€‚ğŸ”»å›¾2æ‰æ˜¯çœŸæ­£çš„çƒè¿·ã€‚#æ¬§å† å†³èµ›# [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh3dkz9gn/">
    
    
    
    
    
      
    
    ğŸ”»è¿™ä¸æ˜¯çœŸæ­£çš„çƒè¿·ã€‚<!-- raw HTML omitted -->ğŸ”»å›¾2æ‰æ˜¯çœŸæ­£çš„çƒè¿·ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#æ¬§å† å†³èµ›#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh3mCCxQn">å¦‚æœæˆ‘æ²¡æœ‰çœ‹é”™çš„è¯ï¼Œä½ æ˜¯åœ¨è´£æ€ªæˆ‘ä»¬æ²¡æœ‰å¹²æ¶‰å¢¨è¥¿å“¥å†…æ”¿å’Œåœ¨å¢¨è¥¿å“¥é©»å†›ï¼Ÿ[å“†å•¦Aæ¢¦åƒæƒŠ]//@å¡å¡”æ˜Œä¸€èˆ¬æ ‘:æ‰€ä»¥ä½ çœ‹ï¼Œä½ ä¸å»ä¿æŠ¤ä½ çš„æµ·å¤–åˆ©ç›Šï¼Œä½ çš„æµ·å¤–èµ„äº§å°±æ˜¯åˆ«...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh3mccxqn/">
    
    
    
    
    
      
    
    å¦‚æœæˆ‘æ²¡æœ‰çœ‹é”™çš„è¯ï¼Œä½ æ˜¯åœ¨è´£æ€ªæˆ‘ä»¬æ²¡æœ‰å¹²æ¶‰å¢¨è¥¿å“¥å†…æ”¿å’Œåœ¨å¢¨è¥¿å“¥é©»å†›ï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@å¡å¡”æ˜Œä¸€èˆ¬æ ‘<!-- raw HTML omitted -->:æ‰€ä»¥ä½ çœ‹ï¼Œä½ ä¸å»ä¿æŠ¤ä½ çš„æµ·å¤–åˆ©ç›Šï¼Œä½ çš„æµ·å¤–èµ„äº§å°±æ˜¯åˆ«äººçš„ææ¬¾æœº<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»å¤šè¯´ä¸¤å¥ï¼Œå¢¨è¥¿å“¥ç°ä»»æ€»ç»Ÿ AMLO &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh3mZmJiK">â€œé‚£èƒ½ä¸€æ ·å—ï¼Ÿâ€//@å¿ƒè„‘è¢‹:å…¶å®å°±å¾ˆç®€å•äº†ï¼Œæ­£ç€æƒ³ä¸æ˜ç™½ï¼Œåè¿‡æ¥æƒ³å°±æ˜¯äº†ã€‚å¤–å›½ä¼ä¸šåœ¨å’±ä»¬è¿™ç»å•†ï¼Œä½ ä¹æ„äººå®¶æŒå‰‘ç»å•†ä¸ï¼Ÿ - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh3mzmjik/">
    
    
    
    
    
      
    
    â€œé‚£èƒ½ä¸€æ ·å—ï¼Ÿâ€//<!-- raw HTML omitted -->@å¿ƒè„‘è¢‹<!-- raw HTML omitted -->:å…¶å®å°±å¾ˆç®€å•äº†ï¼Œæ­£ç€æƒ³ä¸æ˜ç™½ï¼Œåè¿‡æ¥æƒ³å°±æ˜¯äº†ã€‚å¤–å›½ä¼ä¸šåœ¨å’±ä»¬è¿™ç»å•†ï¼Œä½ ä¹æ„äººå®¶æŒå‰‘ç»å•†ä¸ï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»å¸å›½ä¸»ä¹‰çš„æ—¥å­ä¸å¥½è¿‡ã€‚ä¸è¦ç¾¡æ…•å¸å›½ä¸»ä¹‰ã€‚<!-- raw HTML omitted -->ğŸ”»å¸å›½ä¸»ä¹‰çš„å¤§å…¬å¸ï¼Œç°åœ¨ä¹Ÿæ˜¯åœ¨å…¨ä¸–ç•Œé äº¤èµé‡‘ã€èŠ±å…¬å…³è´¹ã€è¯·å¾‹å¸ˆå›¢ã€ä¸Šä¸‹æ‰“ç‚¹ã€é«˜ç«¯ä½ç«¯å•†æˆ˜ä¸€èµ·æ¥ã€æœ‰æ—¶ç”šè‡³è¿˜è¦å–å‹¾å­åšçš„ç”Ÿæ„ï¼Œæœ‰äº›äººå¹»æƒ³ä¸­çš„é‚£ä¸ªä¼ªè£…æˆå…¬å¸çš„å®ä½“å«ä¸œå°åº¦å…¬å¸ï¼Œæ­»å¥½å¤šå¹´äº†ã€‚ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh3nN83jY">ç»™ä½ æ¨èä¸¤æœ¬å°è¯´ï¼Œå¾ˆå¤šå¹´å‰å®Œæœ¬äº†ï¼Œå«ã€Šå›å¾’ã€‹å’Œã€Šé€é¥å†›åŒ»ã€‹ï¼Œæˆ‘ç†Ÿäººé‡åº†çš„è€äº”å†™çš„ï¼Œè®²çš„å°±æ˜¯ä½ è¯´çš„å†…å®¹ï¼Œå»çœ‹å§ï¼Œå¾ˆçˆ½ï¼Œä¸€äº›æƒ…èŠ‚åœ¨ç°åœ¨çš„åœ°ç¼˜æ”¿æ²»ä¸­ç«Ÿç„¶å¾—åˆ°...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh3nn83jy/">
    
    
    
    
    
      
    
    ç»™ä½ æ¨èä¸¤æœ¬å°è¯´ï¼Œå¾ˆå¤šå¹´å‰å®Œæœ¬äº†ï¼Œå«ã€Šå›å¾’ã€‹å’Œã€Šé€é¥å†›åŒ»ã€‹ï¼Œæˆ‘ç†Ÿäººé‡åº†çš„è€äº”å†™çš„ï¼Œè®²çš„å°±æ˜¯ä½ è¯´çš„å†…å®¹ï¼Œå»çœ‹å§ï¼Œå¾ˆçˆ½ï¼Œä¸€äº›æƒ…èŠ‚åœ¨ç°åœ¨çš„åœ°ç¼˜æ”¿æ²»ä¸­ç«Ÿç„¶å¾—åˆ°äº†å°è¯ã€‚//<!-- raw HTML omitted -->@J_has_Image<!-- raw HTML omitted -->:ä½†æ˜¯æˆ‘å¥½æƒ³æˆ‘ä»¬å›½å®¶çš„é›‡ä½£å…µå…¨ä¸–ç•Œæ”¶æˆ˜äº‰èµ”æ¬¾<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh3tWAEzR">ğŸ”»å…‹æ´›æ™®ä¹åœ¨å…¶ä¸­ğŸ¤£ åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh3twaezr/">
    
    
    
    
    
      
    
    ğŸ”»å…‹æ´›æ™®ä¹åœ¨å…¶ä¸­ğŸ¤£ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/uae9G1Y6lx08fk5nFAfK01041200cy4u0E010.mp4?labe">https://f.video.weibocdn.com/o0/uae9G1Y6lx08fk5nFAfK01041200cy4u0E010.mp4?labe</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh3vArRns">ğŸ”»â€œä»Šå¤©çš„å·´è¨çƒè¿·â€ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh3varrns/">
    
    
    
    
    
      
    
    ğŸ”»â€œä»Šå¤©çš„å·´è¨çƒè¿·â€ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/yC3">https://f.video.weibocdn.com/o0/yC3</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh3wribRD">ğŸ”»è¡¨æƒ…åŒ…å‘å®Œäº†ï¼Œç¡è§‰ã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh3wribrd/">
    
    
    
    
    
      
    
    ğŸ”»è¡¨æƒ…åŒ…å‘å®Œäº†ï¼Œç¡è§‰ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh3zfCsBB">æˆ‘æ˜¯æ›¼è”çƒè¿·ï¼Œæˆ‘ä¸ºä»€ä¹ˆè¦çœ‹æ¬§å† å†³èµ›//@KD35Messi10:æ¬§å† å†³èµ›ä¸çœ‹äº† - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»è¡¨æƒ…åŒ…å‘å®Œäº†ï¼Œç¡è§‰ã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh3zfcsbb/">
    
    
    
    
    
      
    
    æˆ‘æ˜¯æ›¼è”çƒè¿·ï¼Œæˆ‘ä¸ºä»€ä¹ˆè¦çœ‹æ¬§å† å†³èµ›//<!-- raw HTML omitted -->@KD35Messi10<!-- raw HTML omitted -->:æ¬§å† å†³èµ›ä¸çœ‹äº†<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»è¡¨æƒ…åŒ…å‘å®Œäº†ï¼Œç¡è§‰ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh43ftfLp">ğŸ”»ä»…æ¬¡äºæ›¼è”çš„æœ€ä½³çƒè¿·ã€‚#æ¬§å† å†³èµ›# åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh43ftflp/">
    
    
    
    
    
      
    
    ğŸ”»ä»…æ¬¡äºæ›¼è”çš„æœ€ä½³çƒè¿·ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#æ¬§å† å†³èµ›#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;div &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh4bF0XNM">ğŸ”»[å“†å•¦Aæ¢¦åƒæƒŠ]#æ¬§å† å†³èµ›# [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh4bf0xnm/">
    
    
    
    
    
      
    
    ğŸ”»<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#æ¬§å† å†³èµ›#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinai">https://tvax1.sinai</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OgX5y4KOs">ä»Šå¤©å„¿ç«¥èŠ‚ï¼Œä¸­å­¦ç¾¤å’Œå¤§å­¦ç¾¤çš„è€å„¿ç«¥ä»¬éƒ½åœ¨äº’ç¥èŠ‚æ—¥å¿«ä¹[é²œèŠ±]æˆ‘åœ¨å¤§ä¸‰çš„æ—¶å€™ï¼Œæ›¾å†™è¿‡ä¸€ç¯‡æœ‰ç‚¹å‡„è¿·çš„çŸ­æ–‡ã€Šç«¥å¿ƒã€‹ï¼Œå‘è¡¨åœ¨æ ¡æŠ¥ä¸Šï¼Œå…¶ä¸­ä¸€èŠ‚äº‘ï¼šâ€œå½“æˆ‘ä»¬ç™½å‘å¦‚é›ª...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ogx5y4kos/">
    
    
    
    
    
      
    
    ä»Šå¤©å„¿ç«¥èŠ‚ï¼Œä¸­å­¦ç¾¤å’Œå¤§å­¦ç¾¤çš„è€å„¿ç«¥ä»¬éƒ½åœ¨äº’ç¥èŠ‚æ—¥å¿«ä¹<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æˆ‘åœ¨å¤§ä¸‰çš„æ—¶å€™ï¼Œæ›¾å†™è¿‡ä¸€ç¯‡æœ‰ç‚¹å‡„è¿·çš„çŸ­æ–‡ã€Šç«¥å¿ƒã€‹ï¼Œå‘è¡¨åœ¨æ ¡æŠ¥ä¸Šï¼Œå…¶ä¸­ä¸€èŠ‚äº‘ï¼šâ€œå½“æˆ‘ä»¬ç™½å‘å¦‚é›ªã€ä¸¤çœ¼æ˜èŠ±çš„æ—¶å€™ï¼Œè¿˜èƒ½æ€€æœ‰ä¸€é¢—ç«¥å¿ƒå—ï¼Ÿæˆ‘çš„æœ‹å‹è¯´ï¼Œå¦‚æœä¸€ä¸ªäººæ²¡æœ‰äº†å­©å­çš„å¤©çœŸï¼Œç•™ä¸‹çš„å°±å…¨æ˜¯åå¿ƒçœ¼ã€‚â€æˆ‘ç°åœ¨è™½ç„¶æ²¡æœ‰ç™½å‘å¦‚é›ªï¼Œä¸¤çœ¼ä¹Ÿæ²¡æœ‰æ˜èŠ±ï¼Œä½†æ¯‹åº¸è®³è¨€ï¼Œäººè€äº†ï¼Œä¸å¯èƒ½æœ‰å­©å­çš„å¤©çœŸï¼Œä½†ç•™ä¸‹çš„å…¨æ˜¯åå¿ƒçœ¼å—ï¼Ÿå‘µå‘µï¼Œè‡ªå·±éª‚è‡ªå·±ï¼ŒçœŸæ˜¯å²‚æœ‰æ­¤ç†ï¼ä¸€ç¬‘ã€‚&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/d1840ee6gy1hq9mw03sy9j20k00zkwj9.jpg%22">https://tvax2.sinaimg.cn/large/d1840ee6gy1hq9mw03sy9j20k00zkwj9.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OgXTvsLDV">ä¸œå›­é£Ÿå ‚å¯èƒ½æ˜¯æ±Ÿå®‰æ ¡åŒºæœ€å·®çš„é£Ÿå ‚ï¼Œèœåšå¾—å¤ªç²—ç³™äº†ï¼Œéš¾æ€ªå—é—¨å¤–çš„å¤§æ’æ¡£é¤é¦†å¤©å¤©éƒ½é‚£ä¹ˆç«çˆ†ã€‚å”¯ä¸€ä¼˜åŠ¿ï¼Œä»·æ ¼æ¯”å¤–é¢é¤é¦†ä¾¿å®œä¸€ç‚¹ï¼Œæ¯›è¡€æ—º10å…ƒï¼Œå’¸çƒ§ç™½8å…ƒï¼Œè—•3å…ƒ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ogxtvsldv/">
    
    
    
    
    
      
    
    ä¸œå›­é£Ÿå ‚å¯èƒ½æ˜¯æ±Ÿå®‰æ ¡åŒºæœ€å·®çš„é£Ÿå ‚ï¼Œèœåšå¾—å¤ªç²—ç³™äº†ï¼Œéš¾æ€ªå—é—¨å¤–çš„å¤§æ’æ¡£é¤é¦†å¤©å¤©éƒ½é‚£ä¹ˆç«çˆ†ã€‚å”¯ä¸€ä¼˜åŠ¿ï¼Œä»·æ ¼æ¯”å¤–é¢é¤é¦†ä¾¿å®œä¸€ç‚¹ï¼Œæ¯›è¡€æ—º10å…ƒï¼Œå’¸çƒ§ç™½8å…ƒï¼Œè—•3å…ƒï¼Œè±†è…3å…ƒï¼Œç±³é¥­2å…ƒã€‚å–µå¥¶å¥¶è¯´ä½ ä¸è¦åœ¨å¾®åšä¸Šä¸œå†™è¥¿å†™ï¼Œæˆ‘è¯´æˆ‘å°±æ˜¯è¦å†™ï¼Œå¥¹è¯´äººå®¶åˆæŠŠä½ æ‹¿æ¥ç¦è¨€ï¼ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/d1840ee6gy1hq9qm">https://tvax2.sinaimg.cn/large/d1840ee6gy1hq9qm</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OgYDa6Hpm">è‘—åæ•™è‚²å®¶ã€è¯­æ–‡ç‰¹çº§æ•™å¸ˆæé•‡è¥¿è€å¸ˆä¸‰å¹´å‰çš„â€œå…­ä¸€å®£è¨€â€ï¼šä¿å«å„¿ç«¥ï¼ã€æé•‡è¥¿ã€‘ä¿å«å„¿ç«¥ï¼â€”â€”æˆ‘çš„ã€Šå…­ä¸€å®£è¨€ã€‹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ogyda6hpm/">
    
    
    
    
    
      
    
    è‘—åæ•™è‚²å®¶ã€è¯­æ–‡ç‰¹çº§æ•™å¸ˆæé•‡è¥¿è€å¸ˆä¸‰å¹´å‰çš„â€œå…­ä¸€å®£è¨€â€ï¼šä¿å«å„¿ç«¥ï¼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ã€æé•‡è¥¿ã€‘ä¿å«å„¿ç«¥ï¼â€”â€”æˆ‘çš„ã€Šå…­ä¸€å®£è¨€ã€‹<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Oh2bWu2cn">ä»Šå¤©é€å£èˆŒä¹‹å¿«ï¼Œåæ§½å››å·å¤§å­¦æ±Ÿå®‰æ ¡åŒºä¸œå›­é£Ÿå ‚ï¼Œå®å±å¿˜è®°åˆå¿ƒã€‚å¤§å­¦æ˜¯æ±‚çŸ¥çš„åœ°æ–¹ï¼Œä¸æ˜¯äº«å—çš„åœ°æ–¹ã€‚æˆ‘é’å¹´æ±‚çŸ¥æ—¶ä»£ï¼Œæœ¬ç§‘åŒ—äº¬é’¢é™¢ï¼Œç¡•å£«å››å·å¸ˆå¤§ï¼Œåšå£«åŒ—äº¬å¸ˆå¤§...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-oh2bwu2cn/">
    
    
    
    
    
      
    
    ä»Šå¤©é€å£èˆŒä¹‹å¿«ï¼Œåæ§½å››å·å¤§å­¦æ±Ÿå®‰æ ¡åŒºä¸œå›­é£Ÿå ‚ï¼Œå®å±å¿˜è®°åˆå¿ƒã€‚å¤§å­¦æ˜¯æ±‚çŸ¥çš„åœ°æ–¹ï¼Œä¸æ˜¯äº«å—çš„åœ°æ–¹ã€‚æˆ‘é’å¹´æ±‚çŸ¥æ—¶ä»£ï¼Œæœ¬ç§‘åŒ—äº¬é’¢é™¢ï¼Œç¡•å£«å››å·å¸ˆå¤§ï¼Œåšå£«åŒ—äº¬å¸ˆå¤§ï¼Œå­¦ç”Ÿé£Ÿå ‚éƒ½ä¸å¯èƒ½ä¸å·å¤§æ±Ÿå®‰æ ¡åŒºçš„ä¸œå›­é£Ÿå ‚æ¯”ã€‚ä½†æˆ‘ä¸ªäººè®¤ä¸ºï¼Œå¿…é¡»æ¯”ï¼Œä¸æˆ‘ä»¬è¿™ä»£äººçš„å¤§å­¦é£Ÿå ‚æ¯”ï¼Œæ‰èƒ½æ¯”å‡ºä»Šå¤©çš„å¹¸ç¦ã€‚ å…ˆæ¯”æœ¬ç§‘é£Ÿå ‚ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OgXF8w1O1">ç¬‘æ­»äº†ï¼Œç¬‘è¯åŸæ¥è¿˜èƒ½å‡çº§[èµ]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ogxf8w1o1/">
    
    
    
    
    
      
    
    ç¬‘æ­»äº†ï¼Œç¬‘è¯åŸæ¥è¿˜èƒ½å‡çº§<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OgYzYxbrI">è½¬å‘å¾®åš - è½¬å‘ @ResonationNmA:&amp;ensp;2024LPLå¤å­£èµ›å®£ä¼ ç‰‡ä¸­çš„å›´æ£‹ã€‚[ç¬‘å“ˆå“ˆ] [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ogyzyxbri/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@ResonationNmA<!-- raw HTML omitted -->:â€‚2024LPLå¤å­£èµ›å®£ä¼ ç‰‡ä¸­çš„å›´æ£‹ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinai">https://tvax4.sinai</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgXOCg9xS">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œã€BLOGã€‘24/05/31 ã€Œé’æ˜¥ã£ã¦å¬‰ã—ãã¦ç´ æ™´ã‚‰ã—ãã¦ç¾å‘³ã—ã„ã­ã€ç¿»è¯‘ç¨å [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogxocg9xs/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ã€BLOGã€‘24/05/31 <!-- raw HTML omitted -->ã€Œé’æ˜¥ã£ã¦å¬‰ã—ãã¦ç´ æ™´ã‚‰ã—ãã¦ç¾å‘³ã—ã„ã­ã€<!-- raw HTML omitted -->ç¿»è¯‘ç¨å &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sina">https://tvax4.sina</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgYza1GcT">ğŸ¥¹//@è§’ç…®å¼å½“:ğŸ˜­//@åºŸè¯å·¨å¤šR :ğŸ˜//@çƒ¤çƒå±€é•¿ :[è£‚å¼€]//@å¤§è±†ç”°è·‘è·‘å­ä¸å‰ä¸‰ä¸ªå· :ğŸ˜°//@æ— è¡¨æƒ…ç‚¸é¸¡ :æƒ³å¥¹ - è½¬å‘ @æšMizuki:&amp;ensp;åˆ†äº«åœ–ç‰‡ [å›¾ç‰‡][å›¾...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogyza1gct/">
    
    
    
    
    
      
    
    ğŸ¥¹//<!-- raw HTML omitted -->@è§’ç…®å¼å½“<!-- raw HTML omitted -->:ğŸ˜­//<!-- raw HTML omitted -->@åºŸè¯å·¨å¤šR<!-- raw HTML omitted --> :ğŸ˜//<!-- raw HTML omitted -->@çƒ¤çƒå±€é•¿<!-- raw HTML omitted --> :<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@å¤§è±†ç”°è·‘è·‘å­ä¸å‰ä¸‰ä¸ªå·<!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oh0fCtohZ">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ é’æ˜¥ã£ã¦å¬‰ã—ãã¦ç´ æ™´ã‚‰ã—ãã¦ç¾å‘³ã—ã„ã­ ã€BLOGã€‘24/05/31é’æ˜¥çœŸæ˜¯è®©äººé«˜å…´ ã€ ç¾å¥½åˆç¾å‘³å‘¢ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oh0fctohz/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://weibo.com/ttarticle/p/show?id=2309405040498359533989%22">https://weibo.com/ttarticle/p/show?id=2309405040498359533989&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oh0fyeDIZ">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.06.01 16:26ã€Œå·å·ã€æœ€è¿‘ï¼Œè¿·ä¸Šäº†æ³¢æµªå¤´ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oh0fyediz/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%259">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oh0z61iOk">æ€ä¹ˆä¸ç®—åƒäº†ç»‡å„¿ä»£è¨€çš„äº§å“ï¼ˆ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oh0z61iok/">
    
    
    
    
    
      
    
    æ€ä¹ˆä¸ç®—åƒäº†ç»‡å„¿ä»£è¨€çš„äº§å“ï¼ˆ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oh35P03da">æˆ‘æœ‰ä¸€åªéº¦å…œå°çŒªåå²é‚£å¹´ç”Ÿæ—¥å§å§ä¹°ç»™æˆ‘çš„é‚£ä¼šå„¿æ˜¯2010å¹´å§å§é‚£å¤©ä¸‹åˆä¸‹è¯¾æ—©éª‘ç€ç”µåŠ¨è½¦è½½ç€æˆ‘å»äº†å¿é‡Œè¾¹æœ€æ—©å¼€ä¸šçš„æ‚è´§å•†åœºæˆ‘ä¹Ÿä¸è®°å¾—ä¸ºä»€ä¹ˆå»äº†ä¸€å®¶æŒ‚æ»¡ç©å¶çš„...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oh35p03da/">
    
    
    
    
    
      
    
    æˆ‘æœ‰ä¸€åªéº¦å…œå°çŒª<!-- raw HTML omitted -->åå²é‚£å¹´ç”Ÿæ—¥å§å§ä¹°ç»™æˆ‘çš„<!-- raw HTML omitted -->é‚£ä¼šå„¿æ˜¯2010å¹´<!-- raw HTML omitted -->å§å§é‚£å¤©ä¸‹åˆä¸‹è¯¾æ—©<!-- raw HTML omitted -->éª‘ç€ç”µåŠ¨è½¦è½½ç€æˆ‘å»äº†å¿é‡Œè¾¹æœ€æ—©å¼€ä¸šçš„æ‚è´§å•†åœº<!-- raw HTML omitted -->æˆ‘ä¹Ÿä¸è®°å¾—ä¸ºä»€ä¹ˆå»äº†ä¸€å®¶æŒ‚æ»¡ç©å¶çš„åº—<!-- raw HTML omitted -->ä½†ä¸€å®šæ˜¯æˆ‘å’Œå§å§è¯´è¿‡æˆ‘æƒ³è¦<!-- raw HTML omitted -->é‚£ä¼šå„¿åº”è¯¥æ˜¯éº¦å…œç”µå½±ä¸Šçº¿äº†æ‰€ä»¥æˆ‘é€‰æ‹©äº†å°çŒª<!-- raw HTML omitted -->åº—å®¶ä¸€å¼€å§‹å¼€å£è¯´ä¸ƒå…«å<!-- raw HTML omitted -->å§å§ç äº†ä»·ç åˆ°å››åä¹°ä¸‹äº†<!-- raw HTML omitted -->å¹´çºªå¾ˆå°ï¼Œå¹¶ä¸çŸ¥é“é‚£ä¸ªæ—¶å€™è¿™æ ·çš„ä»·é’±æ„å‘³ç€ä»€ä¹ˆ<!-- raw HTML omitted -->ä»Šæ™šæˆ‘å¦ˆè¯´è·¯è¾¹å–çš„ç©å¶éƒ½å¾ˆåŠ£è´¨åŠæˆ‘ä»¬ä¸è¦ä¹°<!-- raw HTML omitted -->å¦¹å¦¹æœ—å£°å‘Šè¯‰å¥¹æˆ‘åºŠä¸Šçš„è¿™äº›éƒ½å¾ˆè´µ<!-- raw HTML omitted -->æˆ‘å°±æƒ³èµ·æ¥æˆ‘çš„å°çŒª<!-- raw HTML omitted -->çªç„¶æ„è¯†åˆ°2010å¹´çš„ç‰©ä»·ï¼Œ40å—çœŸçš„å¾ˆè´µ<!-- raw HTML omitted -->è™½ç„¶å°çŒªç¡®å®æ˜¯æˆ‘æ‰€æ‹¥æœ‰çš„è¿™äº›å°å®è´ä»¬é‡Œæœ€ä¾¿å®œçš„<!-- raw HTML omitted -->ä½†æ˜¯æ˜¯æˆ‘æ°¸è¿œæœ€è´µé‡çš„<!-- raw HTML omitted -->å¥½å¤šå¹´é‡Œæˆ‘å¦ˆå‡ æ¬¡å°±æƒ³ä¸¢äº†ï¼Œè¦ä¹ˆæˆ‘è‡ªå·±æ‹¦ä¸‹äº†<!-- raw HTML omitted -->è¦ä¹ˆå¦¹å¦¹å¸®æˆ‘æ‹¦ä¸‹äº†<!-- raw HTML omitted -->è¿™ä¸€ä¸¤å¹´å¦ˆå¦ˆä¹Ÿå­¦ä¼šå°Šé‡æˆ‘ä»¬çš„æƒ³æ³•<!-- raw HTML omitted -->æ²¡æœ‰å†æè¿‡è¦ä¸¢æ‰çš„äº‹æƒ…<!-- raw HTML omitted -->æˆ‘è¿˜æœ‰ä¸€åªç‰¹åˆ«å–œæ¬¢çš„å°ç†Š<!-- raw HTML omitted -->å°±æ˜¯æˆ‘ç»å¸¸è¯´æƒ³ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oh3dKeaoT">æ„Ÿè°¢äº²çˆ¹ææºğŸ¥¹ğŸ«°ğŸ» - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ éº¦å½“åŠ³éº¦è¾£é¸¡å—CMæ‘„å½±åé‡‡è®¿ é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oh3dkeaot/">
    
    
    
    
    
      
    
    æ„Ÿè°¢äº²çˆ¹ææºğŸ¥¹ğŸ«°ğŸ»<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->éº¦å½“åŠ³éº¦è¾£é¸¡å—CMæ‘„å½±åé‡‡è®¿ <!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://video.weibo.com/show?fid=1034:5040590421688351%22">https://video.weibo.com/show?fid=1034:5040590421688351&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgXLyxG4D">ä¹…ä¿å²ç»ªé‡Œã€BLOGã€‘24/05/31 ã€Œé’æ˜¥ã£ã¦å¬‰ã—ãã¦ç´ æ™´ã‚‰ã—ãã¦ç¾å‘³ã—ã„ã­ã€ç¿»è¯‘ç¨å [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogxlyxg4d/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ã€BLOGã€‘24/05/31 <!-- raw HTML omitted -->ã€Œé’æ˜¥ã£ã¦å¬‰ã—ãã¦ç´ æ™´ã‚‰ã—ãã¦ç¾å‘³ã—ã„ã­ã€<!-- raw HTML omitted -->ç¿»è¯‘ç¨å <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgXONkZjM">å†å¢åŠ ä¸€å¼ //@é¡¶ç­†TENä½¿:å¢åŠ ä¸€å¼  - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.ä¹ƒæœ¨ã®ã®&amp;ä¹ƒæœ¨å‚46 X [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogxonkzjm/">
    
    
    
    
    
      
    
    å†å¢åŠ ä¸€å¼ //<!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:å¢åŠ ä¸€å¼ <!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ä¹ƒæœ¨ã®ã®&amp;ä¹ƒæœ¨å‚46 X &lt;img  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgZ2gCVBX">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.06.01 16:26ã€Œå·å·ã€æœ€è¿‘ï¼Œè¿·ä¸Šäº†æ³¢æµªå¤´ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogz2gcvbx/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgZxWcTKF">ä¹…ä¿å²ç»ªé‡Œ é’æ˜¥ã£ã¦å¬‰ã—ãã¦ç´ æ™´ã‚‰ã—ãã¦ç¾å‘³ã—ã„ã­ ã€BLOGã€‘24/05/31é’æ˜¥çœŸæ˜¯è®©äººé«˜å…´ ã€ ç¾å¥½åˆç¾å‘³å‘¢ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogzxwctkf/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09">https://h5.sinaimg.cn/upload/2015/09</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Oh20b3Oli">ä¹…ä¿å²ç»ªé‡Œ éº¦å½“åŠ³éº¦è¾£é¸¡å—CMæ‘„å½±åé‡‡è®¿ é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oh20b3oli/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->éº¦å½“åŠ³éº¦è¾£é¸¡å—CMæ‘„å½±åé‡‡è®¿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/20">https://h5.sinaimg.cn/upload/20</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/Oh11mB4bE">å„¿ç«¥èŠ‚å¿«ä¹[èµ¢ç‰›å¥¶] - è½¬å‘ @æ£‹å£«æŸ¯æ´:&amp;ensp;ç©äº†ä¸€æ•´å¤©æ¸¸æˆï¼Œå„¿ç«¥èŠ‚è¿‡å¾—å¾ˆå……å®ğŸ˜Œç¥å„ä½å¤§å®å®å°å®å®ä»¬å…­ä¸€å„¿ç«¥èŠ‚å¿«ä¹ï¼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-oh11mb4be/">
    
    
    
    
    
      
    
    å„¿ç«¥èŠ‚å¿«ä¹<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@æ£‹å£«æŸ¯æ´<!-- raw HTML omitted -->:â€‚ç©äº†ä¸€æ•´å¤©æ¸¸æˆï¼Œå„¿ç«¥èŠ‚è¿‡å¾—å¾ˆå……å®ğŸ˜Œç¥å„ä½å¤§å®å®å°å®å®ä»¬å…­ä¸€å„¿ç«¥èŠ‚å¿«ä¹ï¼ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701074460">é‡å­ä½å‘è¡¨äº†æ–‡ç« : ControlNetä½œè€…æèµ·å¤§æ¨¡å‹ï¼šè®©å¤©ä¸‹æ²¡æœ‰éš¾å†™çš„ç”Ÿå›¾æç¤ºè¯ï¼Œä¸€å¥è¯å˜æ„å›¾å°ä½œæ–‡</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701074460/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701077714">é‡å­ä½å‘è¡¨äº†æ–‡ç« : å…­ä½ä¸€çº¿AIå·¥ç¨‹å¸ˆæ€»ç»“çˆ†ç«ï¼šå¤§æ¨¡å‹åº”ç”¨æ‘¸çˆ¬æ»šæ‰“ä¸€å¹´å¿ƒå¾—å…¬å¼€</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701077714/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701078941">é‡å­ä½å‘è¡¨äº†æ–‡ç« : AIè¯»è®ºæ–‡æ–°ç¥å™¨ï¼šå¤šæ å¯†é›†æ–‡å­—ã€ä¸­è‹±å›¾æ–‡æ··æ’æ–‡æ¡£éƒ½èƒ½è¯»ï½œæ—·è§†</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701078941/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701084774">é‡å­ä½å‘è¡¨äº†æ–‡ç« : é¦–ä¸ªæ™ºæ…§åŸå¸‚å¤§æ¨¡å‹UrbanGPTï¼Œå…¨é¢å¼€æºå¼€æ”¾ï½œæ¸¯å¤§&amp;ç™¾åº¦</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701084774/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://github.com/521xueweihan/HelloGitHub/blob/master/content/HelloGitHub98.md">ã€ŠHelloGitHubã€‹ç¬¬ 98 æœŸ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/github-com-521xueweihan-hellogithub-blob-master-content-hellogithub98-md/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38816992/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">Quality-of-life outcomes of the ROBOtic-assisted versus Conventional Open Partial nephrectomy (ROBOCOP) II trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38816992-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Pain and physical functioning as subdomains of QoL are improved after RAPN compared to OPN in the early postoperative course, while there are no differences anymore after 3 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38816992/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Quality-of-life outcomes of the ROBOtic-assisted versus Conventional Open Partial nephrectomy (ROBOCOP) II trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38816992-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Pain and physical functioning as subdomains of QoL are improved after RAPN compared to OPN in the early postoperative course, while there are no differences anymore after 3 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38817595/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38817595-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background With more effective therapies for patients with advanced breast cancer (aBC), therapy sequences are becoming increasingly important. However, some patients might drop out of the treatment sequence due to deterioration of their life status. Since little is known about attrition in the real-world setting, this study assessed attrition in the first three therapy lines using a real-world registry. Methods Patients with information available on the first three therapy lines were &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38817595/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38817595-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background With more effective therapies for patients with advanced breast cancer (aBC), therapy sequences are becoming increasingly important. However, some patients might drop out of the treatment sequence due to deterioration of their life status. Since little is known about attrition in the real-world setting, this study assessed attrition in the first three therapy lines using a real-world registry. Methods Patients with information available on the first three therapy lines were &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38817598/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - an Overview of Current Programs</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38817598-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    In recent years, new targeted therapies have been developed to treat patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Some of these therapies have not just become the new therapy standard but also led to significantly longer overall survival rates. The cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) have become the therapeutic standard for first-line therapy. Around 70 - 80% of patients are treated with a CDK4/6i. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38817598/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - an Overview of Current Programs</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38817598-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    In recent years, new targeted therapies have been developed to treat patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Some of these therapies have not just become the new therapy standard but also led to significantly longer overall survival rates. The cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) have become the therapeutic standard for first-line therapy. Around 70 - 80% of patients are treated with a CDK4/6i. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38818145/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">Unintentional injuries and falls in populations in Russia. The Ural eye and medical study and the Ural very old study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38818145-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: UIFs have occurred to a substantial part of the adult and very old population in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38818145/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Unintentional injuries and falls in populations in Russia. The Ural eye and medical study and the Ural very old study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38818145-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: UIFs have occurred to a substantial part of the adult and very old population in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38818593/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">Do Physicians Have a Duty to Support Secondary Use of Clinical Data in Biomedical Research? An Inquiry into the Professional Ethics of Physicians</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38818593-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Secondary use of clinical data in research or learning activities (SeConts) has the potential to improve patient care and biomedical knowledge. Given this potential, the ethical question arises whether physicians have a professional duty to support SeConts. To investigate this question, we analyze prominent international declarations on physicians' professional ethics to determine whether they include duties that can be considered as good reasons for a physicians' professional duty to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38818593/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Do Physicians Have a Duty to Support Secondary Use of Clinical Data in Biomedical Research? An Inquiry into the Professional Ethics of Physicians</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38818593-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Secondary use of clinical data in research or learning activities (SeConts) has the potential to improve patient care and biomedical knowledge. Given this potential, the ethical question arises whether physicians have a professional duty to support SeConts. To investigate this question, we analyze prominent international declarations on physicians' professional ethics to determine whether they include duties that can be considered as good reasons for a physicians' professional duty to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819048/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">Microglia: a promising therapeutic target in spinal cord injury</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819048-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Microglia are present throughout the central nervous system and are vital in neural repair, nutrition, phagocytosis, immunological regulation, and maintaining neuronal function. In a healthy spinal cord, microglia are accountable for immune surveillance, however, when a spinal cord injury occurs, the microenvironment drastically changes, leading to glial scars and failed axonal regeneration. In this context, microglia vary their gene and protein expression during activation, and proliferation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819048/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Microglia: a promising therapeutic target in spinal cord injury</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819048-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Microglia are present throughout the central nervous system and are vital in neural repair, nutrition, phagocytosis, immunological regulation, and maintaining neuronal function. In a healthy spinal cord, microglia are accountable for immune surveillance, however, when a spinal cord injury occurs, the microenvironment drastically changes, leading to glial scars and failed axonal regeneration. In this context, microglia vary their gene and protein expression during activation, and proliferation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819384/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">S100A1&#39;s single cysteine is an indispensable redox-switch for the protection against diastolic calcium wavesin cardiomyocytes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819384-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The EF-hand calcium (Ca^(2+)) sensor protein S100A1 combines inotropic with antiarrhythmic potency in cardiomyocytes (CM). Oxidative posttranslational modification (ox-PTM) of S100A1&rsquo;s conserved, single cysteine residue (C85) via reactive nitrogen species (i.e. S-nitrosylation or glutathionylation) has been proposed to modulate conformational flexibility of intrinsically disordered sequence fragments and to increase the molecule&rsquo;s affinity towards Ca^(2+). In light of the unknown &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819384/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">S100A1&#39;s single cysteine is an indispensable redox-switch for the protection against diastolic calcium wavesin cardiomyocytes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819384-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The EF-hand calcium (Ca^(2+)) sensor protein S100A1 combines inotropic with antiarrhythmic potency in cardiomyocytes (CM). Oxidative posttranslational modification (ox-PTM) of S100A1&rsquo;s conserved, single cysteine residue (C85) via reactive nitrogen species (i.e. S-nitrosylation or glutathionylation) has been proposed to modulate conformational flexibility of intrinsically disordered sequence fragments and to increase the molecule&rsquo;s affinity towards Ca^(2+). In light of the unknown &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819395/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240531182133&amp;v=2.18.0.post9&#43;e462414">Efficacy and Safety of Donidalorsen for Hereditary Angioedema</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819395-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240531182133-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Donidalorsen treatment reduced the hereditary angioedema attack rate, a finding that supports potential prophylactic use for hereditary angioedema. (Funded by Ionis Pharmaceuticals; OASIS-HAE ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819395/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240601181228&amp;v=2.18.0.post9&#43;e462414">Efficacy and Safety of Donidalorsen for Hereditary Angioedema</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819395-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240601181228-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Donidalorsen treatment reduced the hereditary angioedema attack rate, a finding that supports potential prophylactic use for hereditary angioedema. (Funded by Ionis Pharmaceuticals; OASIS-HAE ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819643/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">Nimodipine as Vasodilator in Guide Catheter Flush to Prevent Vasospasm During Endovascular Stroke Treatment</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819643-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Prophylactic adding of nimodipine reduces the risk of vasospasm during EVT without affecting the clinical outcome. Patients with anterior circulation TVO experienced more vasospasm compared to posterior circulation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819643/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Nimodipine as Vasodilator in Guide Catheter Flush to Prevent Vasospasm During Endovascular Stroke Treatment</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819643-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Prophylactic adding of nimodipine reduces the risk of vasospasm during EVT without affecting the clinical outcome. Patients with anterior circulation TVO experienced more vasospasm compared to posterior circulation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819650/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240531182133&amp;v=2.18.0.post9&#43;e462414">New Therapies for Type 1 and Type 2 Hereditary Angioedema</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819650-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240531182133-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819650/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240601181228&amp;v=2.18.0.post9&#43;e462414">New Therapies for Type 1 and Type 2 Hereditary Angioedema</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819650-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240601181228-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819658/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240531182133&amp;v=2.18.0.post9&#43;e462414">Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819658-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240531182133-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Oral sebetralstat provided faster times to the beginning of symptom relief, reduction in attack severity, and complete attack resolution than placebo. (Funded by KalVista Pharmaceuticals; KONFIDENT ClinicalTrials.gov number, NCT05259917; EudraCT number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819658/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240601181228&amp;v=2.18.0.post9&#43;e462414">Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819658-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240601181228-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Oral sebetralstat provided faster times to the beginning of symptom relief, reduction in attack severity, and complete attack resolution than placebo. (Funded by KalVista Pharmaceuticals; KONFIDENT ClinicalTrials.gov number, NCT05259917; EudraCT number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819686/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">Deficit of trainees in thoracic surgery : Do we need to adapt or become extinct?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819686-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Students know exactly what they want for their future and where surgery has its weaknesses. They want transparent and practical training, a work-life balance, and recognition of their work and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819686/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Deficit of trainees in thoracic surgery : Do we need to adapt or become extinct?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819686-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Students know exactly what they want for their future and where surgery has its weaknesses. They want transparent and practical training, a work-life balance, and recognition of their work and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819763/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">Retraction Note: Neurocognitive impairment and patient-proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819763-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819763/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Retraction Note: Neurocognitive impairment and patient-proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819763-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819930/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Determination of energetic positions of electronic states and the exciton dynamics in a Ï€-expanded N-heterotriangulene derivative adsorbed on Au(111)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819930-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Bridged triarylamines, so-called N-heterotriangulenes (N-HTAs) are promising organic semiconductors for applications in optoelectronic devices. Thereby the electronic structure at organic/metal interfaces and within thin films as well as the electronically excited states dynamics after optical excitation is essential for the performance of organic-molecule-based devices. Here, we investigated the energy level alignment and the excited state dynamics of a N-HTA derivative adsorbed on Au(111) &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819973/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&amp;fc=20220814223158&amp;ff=20240601181229&amp;v=2.18.0.post9&#43;e462414">A Vision Transformer-Based Framework for Knowledge Transfer From Multi-Modal to Mono-Modal Lymphoma Subtyping Models</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819973-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1byxlwg-5hn0-qdlgzypdfla2uwghgngzgereuo1rjn2aoaqxp-fc-20220814223158-ff-20240601181229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Determining lymphoma subtypes is a crucial step for better patient treatment targeting to potentially increase their survival chances. In this context, the existing gold standard diagnosis method, which relies on gene expression technology, is highly expensive and time-consuming, making it less accessibility. Although alternative diagnosis methods based on IHC (immunohistochemistry) technologies exist (recommended by the WHO), they still suffer from similar limitations and are less &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820078/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240601181228&amp;v=2.18.0.post9&#43;e462414">Asciminib in Newly Diagnosed Chronic Myeloid Leukemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820078-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240601181228-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In this trial comparing asciminib with investigator-selected TKIs and imatinib, asciminib showed superior efficacy and a favorable safety profile in patients with newly diagnosed chronic-phase CML. Direct comparison between asciminib and second-generation TKIs was not a primary objective. (Funded by Novartis; ASC4FIRST ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820118/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Serum IgG antibodies to HPV6 L1, E2, E4, E6, and E7 proteins among children prospectively followed-up for three years</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820118-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: IgG antibodies against HPV6 E- and L-proteins are transferred from mothers to their children. Seroconversion against HPV6 L1, E2, E4, E6, and E7 does occur in early childhood, as a sign of acquired HPV6 infection by vertical or horizontal transmission starting at 12 months of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820372/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Prospective multicentre accuracy evaluation of the FUJIFILM SILVAMP TB LAM test for the diagnosis of tuberculosis in people living with HIV demonstrates lot-to-lot variability</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820372-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    There is an urgent need for rapid, non-sputum point-of-care diagnostics to detect tuberculosis. This prospective trial in seven high tuberculosis burden countries evaluated the diagnostic accuracy of the point-of-care urine-based lipoarabinomannan assay FUJIFILM SILVAMP TB LAM (FujiLAM) among inpatients and outpatients living with HIV. Diagnostic performance of FujiLAM was assessed against a mycobacterial reference standard (sputum culture, blood culture, and Xpert Ultra from urine and sputum &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820491/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Venovenous bypass in adult liver transplant recipients: A single-center observational case series</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820491-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: VVB continues to play a vital role in LT. This case series highlights the heightened risk of major complications linked to VVB. However, the global transition to selective use of VVB underscores the urgent need for collaborative multi-center studies designed to address outstanding questions and parameters related to the safe implementation of this &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820498/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240601181226&amp;v=2.18.0.post9&#43;e462414">4D intravital imaging identifies platelets as the predominant cellular procoagulant surface in a mouse hemostasis model</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820498-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240601181226-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Interplay between platelets, coagulation factors, endothelial cells (ECs) and fibrinolytic factors is necessary for effective hemostatic plug formation. This study describes a four-dimensional (4D) imaging platform to visualize and quantify hemostatic plug components in mice with high spatiotemporal resolution. Fibrin accumulation following laser-induced vascular injury was observed at the platelet plug-EC interface, controlled by the antagonistic balance between fibrin generation and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820500/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240601181226&amp;v=2.18.0.post9&#43;e462414">Randomized Bendamustine-Rituximab(R) &#43; Bortezomib Induction and R &#43; Lenalidomide Maintenance for Mantle Cell Lymphoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820500-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240601181226-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    While initial therapy of mantle cell lymphoma (MCL) is not standardized, bendamustine-rituximab (BR) is commonly used in older patients. Rituximab (R) maintenance following induction is often utilized. Thus, the open-label, randomized phase II ECOG-ACRIN Cancer Research Group E1411 trial was designed to test two questions: 1) Does addition of bortezomib to BR induction (BVR) and/or 2) addition of lenalidomide to rituximab (LR) maintenance improve progression-free survival (PFS) in patients &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820503/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Exceptional Response of &lt;em&gt;BRAF&lt;/em&gt;&lt;sup&gt;V600E&lt;/sup&gt;-Mutated Acinar Cell CUP to BRAF/MEK Inhibition</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820503-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Complete remission of BRAF V600E-driven ACC CUP by BRAF/MEK inhibition underscores importance of precision &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820588/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240601181226&amp;v=2.18.0.post9&#43;e462414">NOVEL THERAPEUTIC APPROACHES IN THALASSEMIAS, SICKLE CELL DISEASE AND OTHER RED CELL DISORDERS</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820588-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240601181226-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    In this last decade, a deeper understanding of the pathophysiology of hereditary red cell disorders and the development of novel classes of pharmacologic agents have provided novel therapeutic approaches to thalassemias, sickle cell disease (SCD) and other red cell disorders. Here, we analyze and discuss the novel therapeutic options according to their targets and taking into consideration the complex process of erythroid differentiation, maturation, and survival of erythrocytes in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820589/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240601181226&amp;v=2.18.0.post9&#43;e462414">Heme induced loss of renovascular endothelial protein C receptor promotes chronic kidney disease in sickle mice</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820589-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240601181226-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Chronic kidney disease (CKD) is a major contributor to morbidity and mortality in sickle cell disease (SCD). Anemia, induced by chronic persistent hemolysis, is associated with progressive deterioration of renal health resulting in CKD. Moreover, patients with SCD experience acute kidney injury (AKI), a risk factor for CKD, often during vasoocclusive crisis associated with acute intravascular hemolysis. However, the mechanisms of the hemolysis-driven pathogenesis of the AKI-to-CKD transition &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820590/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240601181226&amp;v=2.18.0.post9&#43;e462414">Interleukin-1 mediated hyperinflammation in XIAP-deficiency is associated with defective autophagy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820590-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240601181226-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Deficiency of X-linked Inhibitor of Apoptosis Protein (XIAP) is a rare genetic condition that can present with recurrent episodes of hemophagocytic lymphohistiocytosis (HLH), though the exact mechanisms leading to this hyperinflammatory disorder are unclear. Understanding its biology is critical to developing targeted therapies for this potentially fatal disease. Here we report on a novel multi-exonic intragenic duplication leading to XIAP deficiency with recurrent HLH that demonstrated &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820591/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240601181226&amp;v=2.18.0.post9&#43;e462414">Cardiac complete response in AL amyloidosis has similar survival to matched general population</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820591-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240601181226-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    The survival of patients achieving a cardiac complete response in AL amyloidosis, defined as NT-proBNP â‰¤350 pg/mL or BNP â‰¤80 pg/mL, was similar to a matched general population with an estimated 5-year survival rate of 93% vs 95%, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820608/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Robotic thoracic surgery for neurogenic tumors</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820608-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: RATS for thoracic neurogenic tumors is feasible and safe. Tumors at the thoracic apex are at high risk of neurological deficit and should be approached with care. Close interdisciplinary collaboration between neurosurgeons and thoracic surgeons is necessary for optimal patient selection and a good postoperative &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820715/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240601181018&amp;v=2.18.0.post9&#43;e462414">Masked hypergraph learning for weakly supervised histopathology whole slide image classification</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820715-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240601181018-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: MaskHGL shows a great improvement, brought by considering the intrinsic non-pairwise relationships within WSI, in multiple downstream WSI classification tasks. In particular, the designed masked hypergraph reconstruction module promisingly alleviates the data scarcity and greatly enhances the robustness and classification ability of our MaskHGL. Notably, it has shown great potential in cancer subtyping and fine-grained lung cancer gene mutation prediction from hematoxylin and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820910/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240601181045&amp;v=2.18.0.post9&#43;e462414">Targeted mutational profiling of Epstein Barr virus-positive mucocutaneous ulcer: Implications for differential diagnosis with EBV-positive diffuse large B-cell lymphoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820910-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240601181045-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Epstein Barr Virus-positive mucocutaneous ulcer (EBVMCU) can be difficult to distinguish from EBV-positive diffuse large B cell lymphoma (DLBCL). We used targeted next-generation sequencing (NGS) to explore genetic alterations in EBVMCU to aid in this diagnostic challenge. Ten cases of EBVMCU were evaluated by a targeted NGS panel of 164 genes. Targeted NGS identified 18 variants in 15 genes in eight cases of EBVMCU. Loss of function TET2 variants were most frequently identified (3 of 10 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38821062/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Neural deception: Breast cancer co-opts neuronal mechanisms to evade the immune system</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38821062-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cellular mechanisms mediating immunotherapy resistances are incompletely understood. In this issue, Li et al. reveal how breast cancer hijacks neuronal mechanisms of neuroprotection to shield itself from the immune system. Secretion of N-acetylaspartate impairs immune synapse formation in both neuroinflammation and breast cancer models, paving the way for novel therapeutic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38821074/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240601181045&amp;v=2.18.0.post9&#43;e462414">Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38821074-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240601181045-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Chimeric antigen receptor (CAR) T-cell therapy has shown promise in patients with late-line refractory multiple myeloma, with response rates ranging from 73 to 98%. To date, three products have been approved: Idecabtagene vicleucel (ide-cel) and ciltacabtagene autoleucel (cilta-cel), which are approved by the US Food and Drug Administration, the European Medicines Agency, Health Canada (ide-cel only), and Brazil ANVISA (cilta-cel only); and equecabtagene autoleucel (eque-cel), which was &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38821932/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Aplp1 interacts with Lag3 to facilitate transmission of pathologic Î±-synuclein</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38821932-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Pathologic Î±-synuclein (Î±-syn) spreads from cell-to-cell, in part, through binding to the lymphocyte-activation gene 3 (Lag3). Here we report that amyloid Î² precursor-like protein 1 (Aplp1) interacts with Lag3 that facilitates the binding, internalization, transmission, and toxicity of pathologic Î±-syn. Deletion of both Aplp1 and Lag3 eliminates the loss of dopaminergic neurons and the accompanying behavioral deficits induced by Î±-syn preformed fibrils (PFF). Anti-Lag3 prevents &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38821935/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240601181045&amp;v=2.18.0.post9&#43;e462414">Spatial phenotyping of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38821935-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240601181045-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma with sparse tumor B-cells and a favorable prognosis. Variant growth patterns of NLPHL, however, often show advanced stage, progression to T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL) and a worse prognosis. We studied the tumor microenvironment (TME) of NLPHL and THRLBCL using highplex imaging and spatial profiling at the single cell level. Our findings show distinct differences in TME composition and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OgNRZ3X6l">åœ¨æ–°å† ç–«æƒ…ä¸­å’Œé•¿æ–°å† ï¼ˆLong COVID/PASCï¼‰ç ”ç©¶ä¸­åšå‡ºäº†å“è¶Šè´¡çŒ®ï¼ˆç½‘é¡µé“¾æ¥ï¼‰çš„St Louis VAåœ¨ä»Šå¤©ä¸Šçº¿çš„Nature Medä¸Šå‘è¡¨äº†ä¸€é¡¹ååˆ†é‡è¦çš„é•¿æ–°å† é˜Ÿåˆ—ç ”ç©¶ï¼ŒæŠ¥é“äº†...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ognrz3x6l/">
    
    
    
    
    
      
    
    åœ¨æ–°å† ç–«æƒ…ä¸­å’Œé•¿æ–°å† ï¼ˆLong COVID/PASCï¼‰ç ”ç©¶ä¸­åšå‡ºäº†å“è¶Šè´¡çŒ®ï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½‘é¡µé“¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼‰çš„St Louis VAåœ¨ä»Šå¤©ä¸Šçº¿çš„Nature Medä¸Šå‘è¡¨äº†ä¸€é¡¹ååˆ†é‡è¦çš„é•¿æ–°å† é˜Ÿåˆ—ç ”ç©¶ï¼ŒæŠ¥é“äº†æ„ŸæŸ“SARS-CoV-2åéšè®¿3å¹´æ‚£è€…å‘ç”ŸPASCçš„æƒ…å†µã€‚åœ¨æ„ŸæŸ“SARS-CoV-2åçš„éä½é™¢æ‚£è€…ä¸­ï¼Œåœ¨æ„ŸæŸ“SARS-CoV-2ä¸€å¹´åï¼Œæ‚£è€…å…¨å› æ­»äº¡é£é™©å¹¶æœªå¢åŠ ï¼Œä½†SARS-CoV-2æ„ŸæŸ“åé€ æˆé•¿æ–°å† ä»è€Œå½±å“å·¥ä½œã€ç”Ÿæ´»ï¼ˆDALYsï¼‰å‘ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OgPf1p2K7">æœ¬æœˆBill Schiefç»„ä¸€è¿åœ¨Scienceå’Œå­åˆŠå‘è¡¨äº†4ç¯‡HIVç–«è‹—ç ”ç©¶è®ºæ–‡ï¼ˆç½‘é¡µé“¾æ¥ï¼‰ï¼Œå¼•èµ·äº†å·¨å¤§åå“ï¼›ä»Šå¤©ä¸Šçº¿çš„Nature Immunologyå‘è¡¨äº†è¯¥ç»„å¦ä¸€é¡¹æœ€æ–°çš„HIVç–«è‹—ç ”ç©¶...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ogpf1p2k7/">
    
    
    
    
    
      
    
    æœ¬æœˆBill Schiefç»„ä¸€è¿åœ¨Scienceå’Œå­åˆŠå‘è¡¨äº†4ç¯‡HIVç–«è‹—ç ”ç©¶è®ºæ–‡ï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½‘é¡µé“¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼‰ï¼Œå¼•èµ·äº†å·¨å¤§åå“ï¼›ä»Šå¤©ä¸Šçº¿çš„Nature Immunologyå‘è¡¨äº†è¯¥ç»„å¦ä¸€é¡¹æœ€æ–°çš„HIVç–«è‹—ç ”ç©¶å·¥ä½œï¼Œè¿™é¡¹ç ”ç©¶ä¸Haynesç»„åˆšåˆšå‘è¡¨çš„è®ºæ–‡ï¼ˆ<!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OgUNj77qU">FDAä»Šå¤©æ‰¹å‡†äº†Modernaçš„RSVç–«è‹—ç”¨äº60å²ä»¥ä¸Šäººç¾¤æ¥ç§ã€‚è¿™æ˜¯ç¬¬ä¸‰ä¸ªè¢«æ‰¹å‡†çš„RSVç–«è‹—ã€‚å…¶åœ¨NEJMå‘è¡¨çš„ä¸´åºŠè¯•éªŒç»“æœæ˜¾ç¤ºå…¶æœ‰æ•ˆæ€§ä¸º83.7%ï¼ˆç½‘é¡µé“¾æ¥ï¼‰ï¼›ä½†å…¶æŒä¹…æ€§å¯...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ogunj77qu/">
    
    
    
    
    
      
    
    FDAä»Šå¤©æ‰¹å‡†äº†Modernaçš„RSVç–«è‹—ç”¨äº60å²ä»¥ä¸Šäººç¾¤æ¥ç§ã€‚è¿™æ˜¯ç¬¬ä¸‰ä¸ªè¢«æ‰¹å‡†çš„RSVç–«è‹—ã€‚å…¶åœ¨NEJMå‘è¡¨çš„ä¸´åºŠè¯•éªŒç»“æœæ˜¾ç¤ºå…¶æœ‰æ•ˆæ€§ä¸º83.7%ï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½‘é¡µé“¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼‰ï¼›ä½†å…¶æŒä¹…æ€§å¯èƒ½æ¯”GSK RSVç–«è‹—ç•¥ä½ï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn">https://h5.sinaimg.cn</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/OgOkabVBO">å€Ÿä¹¦è¯„æ¥åšæ¤ç‰©ç§‘æ™®ï¼ŒçœŸæ˜¯ä¸€å¤§å‘æ˜ - è½¬å‘ @å¤©å†¬:&amp;ensp;#å¤©å†¬åšç‰©æ—¥å¿—# è¿™æ˜¯ä¸€æ¡é•¿å¾®åšï¼Œæ¥è¯´è¯´@é©¬ä¼¯åº¸ ã€Šé£Ÿå—ä¹‹å¾’ã€‹é‡Œçš„æ¤ç‰©ã€‚æ—©æ—©å°±ä¹°äº†äº²ç‹é©¬ä¼¯åº¸çš„æ–°ä¹¦ã€Šé£Ÿ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-ogokabvbo/">
    
    
    
    
    
      
    
    å€Ÿä¹¦è¯„æ¥åšæ¤ç‰©ç§‘æ™®ï¼ŒçœŸæ˜¯ä¸€å¤§å‘æ˜<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å¤©å†¬<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->#å¤©å†¬åšç‰©æ—¥å¿—#<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgSF0gBvb">ğŸ”»â€œè°è¯´éª‘å£«ç²¾ç¥å·²æ­»ï¼Ÿâ€ åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogsf0gbvb/">
    
    
    
    
    
      
    
    ğŸ”»â€œè°è¯´éª‘å£«ç²¾ç¥å·²æ­»ï¼Ÿâ€ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/dPFuZ4dalx08fifRzfsk010412003o2y0E010.m">https://f.video.weibocdn.com/o0/dPFuZ4dalx08fifRzfsk010412003o2y0E010.m</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgSHefcbE">ğŸ”»ç›®å‰ä¸ºæ­¢ï¼Œè¿˜æ²¡æœ‰è‰¾æ£®è±ªå¨å°”å·æƒ…å†µçš„å…·ä½“æ¶ˆæ¯ã€‚ğŸ”»æˆ‘ä¼°è®¡ï¼Œä»¥ç°åœ¨ä¹Ÿé—¨è¿™ä¸ªæ‰“å‡»å¯†åº¦ï¼Œè¦æƒ³è®©è¿™ä¸ªæˆ˜æ–—ç¾¤çš„é˜²ç©ºç½‘é¥±å’Œå¹¶ä¸”è¿‡è½½ï¼Œè¿˜æ˜¯æœ‰éš¾åº¦çš„ï¼Œä¹Ÿé—¨ä¹Ÿæ²¡æœ‰å°½å…¨...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogshefcbe/">
    
    
    
    
    
      
    
    ğŸ”»ç›®å‰ä¸ºæ­¢ï¼Œè¿˜æ²¡æœ‰è‰¾æ£®è±ªå¨å°”å·æƒ…å†µçš„å…·ä½“æ¶ˆæ¯ã€‚<!-- raw HTML omitted -->ğŸ”»æˆ‘ä¼°è®¡ï¼Œä»¥ç°åœ¨ä¹Ÿé—¨è¿™ä¸ªæ‰“å‡»å¯†åº¦ï¼Œè¦æƒ³è®©è¿™ä¸ªæˆ˜æ–—ç¾¤çš„é˜²ç©ºç½‘é¥±å’Œå¹¶ä¸”è¿‡è½½ï¼Œè¿˜æ˜¯æœ‰éš¾åº¦çš„ï¼Œä¹Ÿé—¨ä¹Ÿæ²¡æœ‰å°½å…¨åŠ›ã€‚<!-- raw HTML omitted -->ğŸ”»ç°åœ¨ CVN-69 çš„ä½ç½®ï¼Œæ˜¯æ ¹æ®ä¸¤æ¶æ ¼é²æ›¼ C-2 ç°ç‹—å¾€è¿”çš„èˆªè¿¹ç¡®å®šçš„ã€‚<!-- raw HTML omitted -->ğŸ”»è‡³å°‘ç›®å‰ç°ç‹—è¿˜åœ¨é£ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#è‰¾æ£®è±ªå¨å°”å·èˆªæ¯#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/639b1bfbly1hq93zf72fqj20u01gj4qp.jpg%22">https://tvax3.sinaimg.cn/large/639b1bfbly1hq93zf72fqj20u01gj4qp.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgSHu5ZTP">ğŸ”»æ˜æ˜¾æ„Ÿè§‰åˆ°äº†ä¸–ç•Œå˜å±€çš„åŠ é€Ÿåº¦ã€‚#ä¸­æ–¹ç¡®è®¤ä¸å‚åŠ ä¹Œå…‹å…°é—®é¢˜å’Œå¹³å³°ä¼š# [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogshu5ztp/">
    
    
    
    
    
      
    
    ğŸ”»æ˜æ˜¾æ„Ÿè§‰åˆ°äº†ä¸–ç•Œå˜å±€çš„åŠ é€Ÿåº¦ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ä¸­æ–¹ç¡®è®¤ä¸å‚åŠ ä¹Œå…‹å…°é—®é¢˜å’Œå¹³å³°ä¼š#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/639b1bfbly1hq944e9eogj20hp0q7n40.jpg%22">https://tvax4.sinaimg.cn/large/639b1bfbly1hq944e9eogj20hp0q7n40.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgSLC5kkm">ğŸ”»ç«‹é™¶å®›å¤–äº¤éƒ¨é•¿ä¸æ’é™¤ä¹Œå…‹å…°å¯èƒ½å¯¹ç™½ä¿„ç½—æ–¯é¢†åœŸå‘åŠ¨è¢­å‡»ï¼Œç«‹é™¶å®›å¤–äº¤éƒ¨é•¿åŠ å¸ƒé‡ŒåŸƒåˆ©ä¹Œæ–¯Â·å…°èŒ¨è´å‰æ–¯å¯¹åª’ä½“è¡¨ç¤ºï¼Œä¹Œå…‹å…°æœ‰æƒæ‰“å‡»ç™½ä¿„ç½—æ–¯å¢ƒå†…çš„ä¿„ç½—æ–¯å†›äº‹ç›®...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogslc5kkm/">
    
    
    
    
    
      
    
    ğŸ”»ç«‹é™¶å®›å¤–äº¤éƒ¨é•¿ä¸æ’é™¤ä¹Œå…‹å…°å¯èƒ½å¯¹ç™½ä¿„ç½—æ–¯é¢†åœŸå‘åŠ¨è¢­å‡»ï¼Œç«‹é™¶å®›å¤–äº¤éƒ¨é•¿åŠ å¸ƒé‡ŒåŸƒåˆ©ä¹Œæ–¯Â·å…°èŒ¨è´å‰æ–¯å¯¹åª’ä½“è¡¨ç¤ºï¼Œä¹Œå…‹å…°æœ‰æƒæ‰“å‡»ç™½ä¿„ç½—æ–¯å¢ƒå†…çš„ä¿„ç½—æ–¯å†›äº‹ç›®æ ‡ã€‚<!-- raw HTML omitted -->ğŸ”»via å¡”æ–¯ç¤¾<!-- raw HTML omitted -->ğŸ”»æ³¢ä¸‰å°çœŸçš„æ˜¯ã€‚  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgSSDkMRY">ğŸ”»ç½‘å‹æé†’ï¼šå¹¿å·æ²¥å¿ƒæ²™å¤§æ¡¥çš„ä¿®å¤å·¥ä½œå·²ç»è¿›å…¥æœ€åæ”¶å°¾å·¥ç¨‹ï¼Œæ¢å¤é€šè½¦æŒ‡æ—¥å¯å¾…ã€‚ğŸ”»[å“†å•¦Aæ¢¦åƒæƒŠ]ï¼Œè¿™æ‰å¤šä¹…ï¼ŸğŸ”»via @å¹¿å·å—æ²™å‘å¸ƒ å…¬ä¼—å· åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogssdkmry/">
    
    
    
    
    
      
    
    ğŸ”»ç½‘å‹æé†’ï¼šå¹¿å·æ²¥å¿ƒæ²™å¤§æ¡¥çš„ä¿®å¤å·¥ä½œå·²ç»è¿›å…¥æœ€åæ”¶å°¾å·¥ç¨‹ï¼Œæ¢å¤é€šè½¦æŒ‡æ—¥å¯å¾…ã€‚<!-- raw HTML omitted -->ğŸ”»<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼Œè¿™æ‰å¤šä¹…ï¼Ÿ<!-- raw HTML omitted -->ğŸ”»via <!-- raw HTML omitted -->@å¹¿å·å—æ²™å‘å¸ƒ<!-- raw HTML omitted --> å…¬ä¼—å· <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgSSVablE">ğŸ”»å°åº¦é‚£æ ¼æµ¦å°”çš„æ°”æ¸©ä¸º 56 æ‘„æ°åº¦ã€‚ğŸ”»[å“†å•¦Aæ¢¦å®³æ€•] [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogssvable/">
    
    
    
    
    
      
    
    ğŸ”»å°åº¦é‚£æ ¼æµ¦å°”çš„æ°”æ¸©ä¸º 56 æ‘„æ°åº¦ã€‚<!-- raw HTML omitted -->ğŸ”»<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgSTc6lZW">ğŸ”»æ–¯æ‰˜å°”æ»•è´æ ¼æè®®åŒ—çº¦æˆå‘˜å›½æ¯å¹´å‘ä¹Œå…‹å…°æ”¯ä»˜ 400 äº¿ç¾å…ƒã€‚ğŸ”»å¦‚æœä»–ä»¬èƒ½ä¸ºè‡ªå·±çš„äººæ°‘å¼•å¯¼è¿™ç§èƒ½é‡ï¼Œé‚£å°±å¤ªå¥½äº†ã€‚ğŸ”»via vk/smotri_media åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogstc6lzw/">
    
    
    
    
    
      
    
    ğŸ”»æ–¯æ‰˜å°”æ»•è´æ ¼æè®®åŒ—çº¦æˆå‘˜å›½æ¯å¹´å‘ä¹Œå…‹å…°æ”¯ä»˜ 400 äº¿ç¾å…ƒã€‚<!-- raw HTML omitted -->ğŸ”»å¦‚æœä»–ä»¬èƒ½ä¸ºè‡ªå·±çš„äººæ°‘å¼•å¯¼è¿™ç§èƒ½é‡ï¼Œé‚£å°±å¤ªå¥½äº†ã€‚<!-- raw HTML omitted -->ğŸ”»via vk/smotri_media <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax3.sinaimg.cn/orj480/639b1bfbly1hq94xo6i84j21hc0u0dhh.jpg%22">https://tvax3.sinaimg.cn/orj480/639b1bfbly1hq94xo6i84j21hc0u0dhh.jpg&quot;</a> style=&ldquo;width: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgSYa8exI">ğŸ”»æ™šå®‰ã€‚ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogsya8exi/">
    
    
    
    
    
      
    
    ğŸ”»æ™šå®‰ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgTtakUdV">ğŸ”»è‰¾æ£®è±ªå¨å°”å·çš„èˆ°é•¿ Chowdah Hill åˆšåˆšåœ¨è‡ªå·±çš„è´¦å·ä¸Šæ›´æ–°äº†èˆ°ä¸Šçš„å¨æˆ¿ã€‚ğŸ”»çœ‹æ¥ï¼Œå¯èƒ½æ²¡æœ‰é€ æˆè¶³å¤Ÿçš„å¨èƒã€‚#è‰¾æ£®è±ªå¨å°”å·èˆªæ¯# [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogttakudv/">
    
    
    
    
    
      
    
    ğŸ”»è‰¾æ£®è±ªå¨å°”å·çš„èˆ°é•¿ Chowdah Hill åˆšåˆšåœ¨è‡ªå·±çš„è´¦å·ä¸Šæ›´æ–°äº†èˆ°ä¸Šçš„å¨æˆ¿ã€‚<!-- raw HTML omitted -->ğŸ”»çœ‹æ¥ï¼Œå¯èƒ½æ²¡æœ‰é€ æˆè¶³å¤Ÿçš„å¨èƒã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#è‰¾æ£®è±ªå¨å°”å·èˆªæ¯#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/639b1bfbly1hq97i0">https://tvax4.sinaimg.cn/large/639b1bfbly1hq97i0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgTznoF4j">ä¸ç®¡å¤§å®¶ä¿¡ä¸ä¿¡ï¼Œä¹Ÿç®—æ˜¯ä¸ªé˜´é˜³æ€ªæ°”çš„å›åº”å§ã€‚è¿™èˆ°é•¿ä¸€è´¯æŒºé˜´é˜³çš„ï¼Œå¥½å‡ æ¬¡äº†ã€‚//@ä»Šä»Šå¤©ä¸å¿«æ¨‚:è¿™å°±æ„Ÿè§‰æ•…æ„æ­¤åœ°æ— é“¶çš„æ„Ÿè§‰[æ‘Šæ‰‹] - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogtznof4j/">
    
    
    
    
    
      
    
    ä¸ç®¡å¤§å®¶ä¿¡ä¸ä¿¡ï¼Œä¹Ÿç®—æ˜¯ä¸ªé˜´é˜³æ€ªæ°”çš„å›åº”å§ã€‚è¿™èˆ°é•¿ä¸€è´¯æŒºé˜´é˜³çš„ï¼Œå¥½å‡ æ¬¡äº†ã€‚//<!-- raw HTML omitted -->@ä»Šä»Šå¤©ä¸å¿«æ¨‚<!-- raw HTML omitted -->:è¿™å°±æ„Ÿè§‰æ•…æ„æ­¤åœ°æ— é“¶çš„æ„Ÿè§‰<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»è‰¾æ£®è±ªå¨å°”å·çš„èˆ°é•¿ Chowdah Hill åˆšåˆšåœ¨è‡ªå·±çš„è´¦å·ä¸Šæ›´æ–°äº†èˆ°ä¸Šçš„å¨æˆ¿ã€‚<!-- raw HTML omitted -->ğŸ”»çœ‹æ¥ï¼Œå¯èƒ½æ²¡æœ‰é€ æˆè¶³å¤Ÿçš„å¨èƒã€‚<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%25">https://m.weibo.cn/search?containerid=231522type%3D1%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OgNAGhVYl">6ï¼š20é†’æ¥ï¼Œå…ˆå‡è£…é™¶æ¸Šæ˜ï¼Œè§†å¯Ÿé›¨åèœå›­ï¼Œç„¶åæ—©é¤ï¼Œä¼æ¡ˆå·¥ä½œï¼Œç»§ç»­åœ¨ã€Šç§è±†å¾—ç“œé›†ã€‹æ‰‰é¡µé¢˜è¯ç­¾åé’¤å°ï¼Œè‡³9ï¼š30ï¼Œå®Œæˆ152å¼ ï¼ŒåŠ ä¸Šæ˜¨å¤©æ™šä¸Šå®Œæˆçš„50å¤šå¼ ï¼Œå·²ç»è¿‡...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ognaghvyl/">
    
    
    
    
    
      
    
    6ï¼š20é†’æ¥ï¼Œå…ˆå‡è£…é™¶æ¸Šæ˜ï¼Œè§†å¯Ÿé›¨åèœå›­ï¼Œç„¶åæ—©é¤ï¼Œä¼æ¡ˆå·¥ä½œï¼Œç»§ç»­åœ¨ã€Šç§è±†å¾—ç“œé›†ã€‹æ‰‰é¡µé¢˜è¯ç­¾åé’¤å°ï¼Œè‡³9ï¼š30ï¼Œå®Œæˆ152å¼ ï¼ŒåŠ ä¸Šæ˜¨å¤©æ™šä¸Šå®Œæˆçš„50å¤šå¼ ï¼Œå·²ç»è¿‡åŠã€‚æç¬”ï¼Œæ›´è¡£ï¼Œæ­£è¦å‡ºé—¨ï¼Œå»å°å–µå®¶å½“é¥²å…»å‘˜ï¼Œä¸Šçº§æ¥ç”µï¼Œä½ ä»Šå¤©å¯ä»¥ä¸è¿‡æ¥åšæ™šé¥­äº†ï¼å–µçˆ¸è¯´æ™šä¸Šä¹°è£æ˜Œå¤é¹…ï¼Œæˆ‘å†ç»™ä»–ä»¬ç…®ä¸¤æ ¹é¦™è‚ ï¼Œç‚’ä¸€ä¸ªç´ èœå°±è¡Œäº†ã€‚å¥¹è¯´è¡Œä¸è¡Œï¼Ÿæˆ‘è¯´æœä»ä¸Šçº§å®‰æ’ï¼Œå¥¹è¯´å¥½ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/d1840ee6gy1hq8gphrj6tj237k2eok">https://tvax3.sinaimg.cn/large/d1840ee6gy1hq8gphrj6tj237k2eok</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OgOq6lIxS">æœ¬æ¥æƒ³å»åƒæ•™å·¥é£Ÿå ‚è‡ªåŠ©é¤ï¼Œä½†ä¸€å‡ºå°åŒºé—¨ï¼Œæ„Ÿè§‰å¤©æ°”å¤ªçƒ­ï¼Œé©¬ä¸Šæ”¹å˜ä¸»æ„ï¼Œåˆ°â€œä¿æ±Ÿå®‰â€ç¾é£Ÿé¤å§æ¥è§£å†³åˆé¤ã€‚ç¾é£Ÿå¤ªå¤šï¼Œä»¤äººçœ¼èŠ±ç¼­ä¹±ï¼Œè½¬äº†ä¸€å¤§åœˆï¼Œæœ€åé€‰å®šé™•è¥¿å‡‰...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ogoq6lixs/">
    
    
    
    
    
      
    
    æœ¬æ¥æƒ³å»åƒæ•™å·¥é£Ÿå ‚è‡ªåŠ©é¤ï¼Œä½†ä¸€å‡ºå°åŒºé—¨ï¼Œæ„Ÿè§‰å¤©æ°”å¤ªçƒ­ï¼Œé©¬ä¸Šæ”¹å˜ä¸»æ„ï¼Œåˆ°â€œä¿æ±Ÿå®‰â€ç¾é£Ÿé¤å§æ¥è§£å†³åˆé¤ã€‚ç¾é£Ÿå¤ªå¤šï¼Œä»¤äººçœ¼èŠ±ç¼­ä¹±ï¼Œè½¬äº†ä¸€å¤§åœˆï¼Œæœ€åé€‰å®šé™•è¥¿å‡‰çš®å’Œæ–°ç–†çƒ¤ç¾Šè‚‰ä¸²ã€‚ç¾Šè‚‰ä¸²å‘³é“å°šå¯ï¼Œä½†åƒä¸å‡ºç¾Šè‚‰å‘³ï¼Œé—®çƒ¤è‚‰äººï¼Œä½ è¿™æ˜¯æ–°ç–†ç¾Šè‚‰å—ï¼Ÿä»–è¯´ä¸æ˜¯æ–°ç–†ç¾Šè‚‰ï¼Œæ˜¯å®å¤æ»©ç¾Šã€‚æˆ‘è¯´æ€ä¹ˆåƒä¸å‡ºç¾Šè‚‰å‘³å‘¢ï¼Ÿä»–è¯´å®å¤æ»©ç¾Šæ²¡æœ‰è†»å‘³ã€‚æˆ‘æœ¬æ¥æƒ³è¯´éš¾é“æ–°ç–†ç¾Šè‚‰æœ‰è†»å‘³ï¼Ÿä½†å¦‚æœä»–ä¸é¡¾äº‹å®ï¼ŒåšæŒè¯´é€—æ˜¯ï¼Œæˆ‘ä¹Ÿæ— æ³•åé©³ä»–ï¼Œå°±è¯´ä½ æ—¢ç„¶æ˜¯æ–°ç–†çƒ¤ç¾Šè‚‰ä¸²ï¼Œå’‹ä¸ç”¨æ–°ç–†ç¾Šè‚‰ï¼Ÿä»–è¯´æ–°ç–†å¤ªè¿œäº†ï¼Œè¿›ä¸æ¥ã€‚æˆ‘è¯´æˆéƒ½å°±æœ‰ä¸€å®¶æ–°ç–†ç¾Šè‚‰åº—ï¼Œåœ¨æŠšç´è·¯ï¼Œå¯ä»¥é€è´§ä¸Šé—¨ï¼Œæˆ‘å®¶å»å¹´è¿˜ä¹°è¿‡å‡ åæ–¤ã€‚ä»–å°±ä¸è¨€è¯­äº†ã€‚æˆ‘ä¹Ÿä¸æƒ³å’Œä»–äº‰è¾©ï¼Œåæ­£ä»Šåæˆ‘ä¸ä¼šå†æ¥åƒä»–çš„æ²¡æœ‰ç¾Šè‚‰å‘³çš„çƒ¤ç¾Šè‚‰ä¸²äº†ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/d1840ee6gy1hq8jy10if5">https://tvax2.sinaimg.cn/large/d1840ee6gy1hq8jy10if5</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OgSv70ctG">ä»æ—©åˆ°æ™šï¼Œéƒ½åœ¨ä¸ºå³å°†é—®ä¸–çš„ã€Šç§è±†å¾—ç“œé›†ã€‹é¢˜è¯ã€ç­¾åã€é’¤å°ï¼Œæ²¡æœ‰åå‹¤ä¿éšœï¼Œåˆé¤åœ¨å°åŒºå¤–é¢çš„â€œä¿æ±Ÿå®‰ç¾é£Ÿå§â€åƒé™•è¥¿å‡‰çš®å’Œæ–°ç–†çƒ¤å®å¤ç¾Šè‚‰ä¸²ï¼Œéƒ½ä¸æ»¡æ„ã€‚æ™šé¤æ€...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ogsv70ctg/">
    
    
    
    
    
      
    
    ä»æ—©åˆ°æ™šï¼Œéƒ½åœ¨ä¸ºå³å°†é—®ä¸–çš„ã€Šç§è±†å¾—ç“œé›†ã€‹é¢˜è¯ã€ç­¾åã€é’¤å°ï¼Œæ²¡æœ‰åå‹¤ä¿éšœï¼Œåˆé¤åœ¨å°åŒºå¤–é¢çš„â€œä¿æ±Ÿå®‰ç¾é£Ÿå§â€åƒé™•è¥¿å‡‰çš®å’Œæ–°ç–†çƒ¤å®å¤ç¾Šè‚‰ä¸²ï¼Œéƒ½ä¸æ»¡æ„ã€‚æ™šé¤æ€ä¹ˆè§£å†³ï¼Ÿ<!-- raw HTML omitted --> å–µçˆ·çˆ·ç‹¬ç«‹ç”Ÿæ´»èƒ½åŠ›è¶…å¼ºï¼Œå‘ç°å†°ç®±æœ‰ä¸€ä¸ªæ¼ç½‘çš„åœŸè±†ï¼Œå¤•é˜³è¥¿ä¸‹æ–­è‚ äººåœ¨å¤©æ¶¯çš„æ—¶å€™ï¼Œå»èœå›­æ‘˜äº†å‡ ä¸ªäºŒè†æ¡è¾£æ¤’ï¼Œç‚’åœŸè±†ä¸ã€‚ä¸€èœä¸€é¥­ï¼Œæ˜¯æˆ‘ä»¬é’å°‘å¹´æ—¶ä»£çš„æ ‡é…ï¼Œå–µçˆ·çˆ·åƒå¾—æ´¥æ´¥æœ‰å‘³ã€‚<!-- raw HTML omitted --> ç¢—ç­·æˆ‘æ˜¯ä¸ä¼šæ´—çš„ï¼Œåšå†³ä¸æ´—ï¼Œå› ä¸ºæ´—ç¢—å·¥æ˜¯å–µå¥¶å¥¶æ‰¿åŒ…äº†çš„ã€‚å¤«å¦»ä¹Ÿåº”è¯¥æœ‰å¥‘çº¦ç²¾ç¥ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/d1840ee6gy1hq92n0q9tuj22bc334e8">https://tvax2.sinaimg.cn/large/d1840ee6gy1hq92n0q9tuj22bc334e8</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OgOtToqHQ">æ˜¯è¿™æ ·çš„ï¼Œå¯¹å±€çš„æ£‹æ‰‹åªè¦å…¨èº«å¿ƒæŠ•å…¥åˆ°æ£‹å±€ä¸­ï¼Œä¸‹å‡ºä¸€é€‰ï¼Œå¥‹åŠ›èµ¢æ£‹å°±å¯ä»¥ï¼Œå¯æ˜¯è§‚æˆ˜çš„é”®ç›˜ä¾ ä»¬è¦è€ƒè™‘çš„äº‹æƒ…å°±å¾ˆå¤šäº†[doge]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ogottoqhq/">
    
    
    
    
    
      
    
    æ˜¯è¿™æ ·çš„ï¼Œå¯¹å±€çš„æ£‹æ‰‹åªè¦å…¨èº«å¿ƒæŠ•å…¥åˆ°æ£‹å±€ä¸­ï¼Œä¸‹å‡ºä¸€é€‰ï¼Œå¥‹åŠ›èµ¢æ£‹å°±å¯ä»¥ï¼Œå¯æ˜¯è§‚æˆ˜çš„é”®ç›˜ä¾ ä»¬è¦è€ƒè™‘çš„äº‹æƒ…å°±å¾ˆå¤šäº†<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OgRwxrJl7">å–äº†ä¸€æ¯æ‹¿é“ï¼Œæ„Ÿè§‰å¿«ç¡ç€äº†[äºŒå“ˆ]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ogrwxrjl7/">
    
    
    
    
    
      
    
    å–äº†ä¸€æ¯æ‹¿é“ï¼Œæ„Ÿè§‰å¿«ç¡ç€äº†<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgNSywpaj">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.å²¡ç”°å‡†ä¸€ Xä¿¡é•¿æ—¶ä»£çš„å¥³å„¿ä¹…ä¿å²ç»ªé‡Œæ¡‘çš„è„¸é¢Šè½¯ä¹ä¹çš„ï¼Œå¾ˆéš¾ä¸‹å¾—äº†æ‰‹å»çŒ›æŠ“ã€‚å› ä¸ºå½“æ—¶æ˜¯çªç„¶è¿™æ ·åšçš„æ‰€ä»¥è¿˜ä»¥...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ognsywpaj/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.å²¡ç”°å‡†ä¸€ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgNV4nFnJ">è½¬å‘å¾®åš - è½¬å‘ @å‰‘ç½‘3å®˜æ–¹å¾®åš:&amp;ensp;ä¸å¯æ€è®®ï¼Œæ— ç•Œç›¸é€¢ï¼å…«å¤§è”åŠ¨å†…å®¹é™ªä½ å…±è¿æ— ç•Œï¼çº¿ä¸‹çº¿ä¸Šå¤§ç‹‚æ¬¢~ä¾ å£«ä»¬å‡†å¤‡å¥½äº†å˜›ï¼è½¬å…³æŠ½5ä½ä¾ å£«é€ä¸Šã€613ç°é‡‘çº¢åŒ…ã€‘ï¼Œ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ognv4nfnj/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å‰‘ç½‘3å®˜æ–¹å¾®åš<!-- raw HTML omitted -->:â€‚ä¸å¯æ€è®®ï¼Œæ— ç•Œç›¸é€¢ï¼å…«å¤§è”åŠ¨å†…å®¹é™ªä½ å…±è¿æ— ç•Œï¼çº¿ä¸‹çº¿ä¸Šå¤§ç‹‚æ¬¢~ä¾ å£«ä»¬å‡†å¤‡å¥½äº†å˜›ï¼è½¬å…³æŠ½5ä½ä¾ å£«é€ä¸Šã€613ç°é‡‘çº¢åŒ…ã€‘ï¼Œè¯„è®ºåŒºå†æŠ½5ä½å¹¸è¿ä¾ å£«é€ä¸Šã€20000é€šå®ã€‘<!-- raw HTML omitted -->@å¾®åšæŠ½å¥–å¹³å°<!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->å¼€å§‹æ‘‡äººå•¦ï¼å®˜åšå›ä¸ºå¤§å®¶åˆ’è”åŠ¨é‡ç‚¹å•¦ â†“<!-- raw HTML omitted -->â— åŠå…¬æ— ç•Œï¼Œæ±Ÿæ¹–ç›¸èšï¼WPSè”åŠ¨æ´»åŠ¨è®©åŠå…¬ä¸æ±Ÿæ¹–éƒ½å¯ä»¥è½»æ¾ç•…æ¸¸ï¼<!-- raw HTML omitted -->â— å–œæå¤–å–ï¼Œæ¬¢ç¬‘æ— ç•Œï¼å‰‘ç½‘3 Ã— ç¾å›¢å¤–å– Ã— DQä¸‰æ–¹è”åŠ¨é™ªä½ åº¦è¿‡æ¸…çˆ½å¤å¤©ï¼<!-- raw HTML omitted -->â— ä¸‹å¤©ä¸Šæµ·ï¼Œç›¸èšæ— ç•Œï¼å·¨å‹é»„é¸¡å¤§ç¬‘6æœˆå³å°†å¼€å¯ä¸€åœºä¸Šæµ·æ‰“å¡å·¡æ¸¸ï¼<!-- raw HTML omitted -->â— å¤§å”ç››ç­µï¼Œç•ªè–¯æ— ç•Œï¼å‰‘ç½‘3æºæ‰‹éé—ä¼ äººç•ªè–¯ç©å®¶æ±Ÿå¯»åƒï¼ˆä¹æœˆï¼‰å¼€å¯è·¨ç•Œçš„ä¼ æ‰¿ä¹‹æ—…ï¼<!-- raw HTML omitted -->â— åäº”å‘¨å¹´ï¼Œä¹äº«æ— ç•Œï¼åäº”å‘¨å¹´ç››å…¸è½åœ°æ­å·å°è²èŠ±ï¼æ¼”å”±ä¼šMIX &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgOfCowcT">è½¬å‘å¾®åš - è½¬å‘ @éº¦å½“åŠ³:&amp;ensp;âœï¸çœ‹äº†å†…éƒ¨èµ„æ–™ï¼Œå¿ä¸ä½æ³„å¯†ï¼šå…­ä¸€å½“å¤©ï¼Œä¹°ã€20å…ƒ20å—éº¦ä¹é¸¡ã€‘ï¼Œä¼šè§¦å‘ç¥ç§˜äººç‰©å¤šé€ä½ ä¸€å—ï¼[å˜˜]#ä¸€å—éº¦ä¹é¸¡ä¸€å—å¤šå¼€å¿ƒ#ğŸš«è¯·...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogofcowct/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@éº¦å½“åŠ³<!-- raw HTML omitted -->:â€‚âœï¸çœ‹äº†å†…éƒ¨èµ„æ–™ï¼Œå¿ä¸ä½æ³„å¯†ï¼šå…­ä¸€å½“å¤©ï¼Œä¹°ã€20å…ƒ20å—éº¦ä¹é¸¡ã€‘ï¼Œä¼šè§¦å‘ç¥ç§˜äººç‰©å¤šé€ä½ ä¸€å—ï¼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%80%E5%9D%97%E9%BA%A6%E4%B9%90%E9%B8%A1%E4%B8%80%E5%9D%97%E5%A4%9A%E5%BC%80%E5%BF%83%23&amp;amp;extparam=%23%E4%B8%80%E5%9D%97%E9%BA%A6%E4%B9%90%E9%25B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%80%E5%9D%97%E9%BA%A6%E4%B9%90%E9%B8%A1%E4%B8%80%E5%9D%97%E5%A4%9A%E5%BC%80%E5%BF%83%23&amp;amp;extparam=%23%E4%B8%80%E5%9D%97%E9%BA%A6%E4%B9%90%E9%B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgPKZ0uIj">è½¬å‘å¾®åš - è½¬å‘ @å‰‘ç½‘3å®˜æ–¹å¾®åš:&amp;ensp;ä¾ å£«è¿˜è®°å¾—2013å¹´å¼€å¯çš„â€œæˆ‘ä¸ºå‰‘ç½‘3ä»£è¨€æ´»åŠ¨â€å—ï¼Ÿéšç€ã€Šå‰‘ç½‘3ã€‹å…¨å¹³å°ä¸Šçº¿çš„ä¸´è¿‘ï¼Œå…¨æ–°æ¿€åŠ±å›é¦ˆæ´»åŠ¨éœ‡æ’¼æ¥è¢­ï¼Œè¿™æ¬¡å°±æ˜¯...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogpkz0uij/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å‰‘ç½‘3å®˜æ–¹å¾®åš<!-- raw HTML omitted -->:â€‚ä¾ å£«è¿˜è®°å¾—2013å¹´å¼€å¯çš„â€œæˆ‘ä¸ºå‰‘ç½‘3ä»£è¨€æ´»åŠ¨â€å—ï¼Ÿ<!-- raw HTML omitted -->éšç€ã€Šå‰‘ç½‘3ã€‹å…¨å¹³å°ä¸Šçº¿çš„ä¸´è¿‘ï¼Œå…¨æ–°æ¿€åŠ±å›é¦ˆæ´»åŠ¨éœ‡æ’¼æ¥è¢­ï¼Œè¿™æ¬¡å°±æ˜¯è¦ç®€å•ç›´æ¥ï¼ç»§ç™»å½•é€æ ¡æœã€æ»¡çº§é€æ ¡æœåï¼Œå…è´¹æ ¡æœå†æ¥ä¸‰å¥—ï¼5471å¥—æ ¡æœä»»ä½ é€‰ï¼æ‹‰ä¸Šäº²å‹ï¼Œä¸€èµ·æ¥æ‹¿å¥½ç¤¼å§~6æœˆ6æ—¥æ´»åŠ¨æ­£å¼å¼€å¯ï¼<!-- raw HTML omitted --><!-- raw HTML omitted -->å¾ˆå¤šä¾ å£«æƒ³è®©å®˜åšé€æ‰‹æœºï¼è¿™æ¬¡çœŸçš„æ¥é€å•¦~è½¬å…³æŠ½1ä½å¹¸è¿ä¾ å£«é€ä¸Šã€Xiaomi 14 Pro 16+512ç‰ˆã€‘ï¼Œå†æŠ½1ä½å¹¸è¿ä¾ å£«é€ä¸Šã€iPad Air6 512ç‰ˆã€‘ï¼å†å†ä»è¯„è®ºåŒºæŠ½10ä½å¹¸è¿ä¾ å£«é€ä¸Šã€10000é€šå®ã€‘<!-- raw HTML omitted -->@å¾®åšæŠ½å¥–å¹³å°<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->âœ¦ ã€é€æ ¡æœå•¦ï¼ä¸æ­¢ä¸€å¥—ã€‘æ»¡çº§å³å¯æ‹¿è‡ªé€‰åˆ¸ï¼å‚ä¸å¥½å‹åŒè¡Œæ´»åŠ¨æœ€é«˜è¿˜èƒ½é¢å¤–æ‹¿3å¼ æ ¡æœè‡ªé€‰åˆ¸ï¼æ‰‹æ¡1+3å¼ æ ¡æœè‡ªé€‰åˆ¸ï¼Œè¸ä¸Šå¤§å”æ­é…ç•Œç‹è€…ä¹‹è·¯ï¼&lt;br &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgQuZCOMT">æ˜¯è°ï¼Œåœ¨å‰‘ç½‘ä¸‰ä¸Šç­ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogquzcomt/">
    
    
    
    
    
      
    
    æ˜¯è°ï¼Œåœ¨å‰‘ç½‘ä¸‰ä¸Šç­ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgS3L1CC6">å·æ„Ÿå¾ˆé‡ï¼Œæ‚„æ‚„å¹¸ç¦[è€å¸ˆçˆ±ä½ ] [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogs3l1cc6/">
    
    
    
    
    
      
    
    å·æ„Ÿå¾ˆé‡ï¼Œæ‚„æ‚„å¹¸ç¦<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgSBmys1g">è½¬å‘å¾®åš - è½¬å‘ @æšMizuki:&amp;ensp;ï¼œæ˜ ç”»ã€Œå¸°ã£ã¦ããŸ ã‚ã¶ãªã„åˆ‘äº‹ã€ï¼ˆ5æœˆ24æ—¥å…¬é–‹ï¼‰æ—©ç€¬æ¢¨èŠ±å½¹ãƒ»è¥¿é‡ä¸ƒç€¬ãƒ¢ãƒ‡ãƒ«ãƒ—ãƒ¬ã‚¹ã‚¤ãƒ³ã‚¿ãƒ“ãƒ¥ãƒ¼ï¼ #ãªãã¡ã‚ƒã‚“# ç½‘é¡µé“¾æ¥ [...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogsbmys1g/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@æšMizuki<!-- raw HTML omitted -->:â€‚ï¼œæ˜ ç”»ã€Œå¸°ã£ã¦ããŸ ã‚ã¶ãªã„åˆ‘äº‹ã€ï¼ˆ5æœˆ24æ—¥å…¬é–‹ï¼‰æ—©ç€¬æ¢¨èŠ±å½¹ãƒ»è¥¿é‡ä¸ƒç€¬ãƒ¢ãƒ‡ãƒ«ãƒ—ãƒ¬ã‚¹ã‚¤ãƒ³ã‚¿ãƒ“ãƒ¥ãƒ¼ï¼ <!-- raw HTML omitted --><!-- raw HTML omitted -->#ãªãã¡ã‚ƒã‚“#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_web_default.png%22">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_web_default.png&quot;</a> referrerpolicy=&ldquo;no-refer &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgTGWqW8X">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#shiorigram##ä¹ƒæœ¨å‚46ANN##é€šçŸ¥å„ä½å¬ä¼—##æˆ‘çœŸçš„åŠ tagäº†å“¦#è¯¦æƒ…è¯·å¬å¬è¿™å‘¨çš„å¹¿æ’­å“¦ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogtgwqw8x/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extpara">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extpara</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgTH498Ss">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œä¹ƒæœ¨æ‹æ–°å¡ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogth498ss/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ƒæœ¨æ‹æ–°å¡ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1hq90wnn7u7j30hs0nqn37.jpg%22">https://tvax2.sinaimg.cn/large/006z6nxLgy1hq90wnn7u7j30hs0nqn37.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgTntaSaU">å¥½ç¥å¥‡ï¼Œèƒ½å¬æ‡‚æ—¥è¯­çš„æ—¶å€™æ„Ÿè§‰å¥½ç¥å¥‡</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogtntasau/">
    
    
    
    
    
      
    
    å¥½ç¥å¥‡ï¼Œèƒ½å¬æ‡‚æ—¥è¯­çš„æ—¶å€™æ„Ÿè§‰å¥½ç¥å¥‡  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OgNn0c0Vh">m [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ognn0c0vh/">
    
    
    
    
    
      
    
    m <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OgPfn64dM">ä¹…ä¿å§‹çƒå¼é‚£å¤©çš„é å”®ç¥¨è³£å…‰å•¦ï¼[åŠªåŠ›] [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ogpfn64dm/">
    
    
    
    
    
      
    
    ä¹…ä¿å§‹çƒå¼é‚£å¤©çš„é å”®ç¥¨è³£å…‰å•¦ï¼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OgQiqp4Jc">ä½ ä¿å¯«blog äº†ï¼å¯å–œå¯è³€ğŸ‘ğŸ‘ğŸ‘ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ogqiqp4jc/">
    
    
    
    
    
      
    
    ä½ ä¿å¯«blog äº†ï¼å¯å–œå¯è³€ğŸ‘ğŸ‘ğŸ‘ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgOI2j2Uo">å› ä¸ºæˆ‘æ˜¯å…è´¹ä¼šå‘˜ï¼Œçœ‹ä¸åˆ°è€èµµè¿è½½çš„æœ€æ–°å†…å®¹ï¼Œä¸è¿‡å¬è¯´è¿™ç¯‡è¿è½½é‡Œé¢æœ‰æåˆ°å¾ˆå¤šä¹‹å‰è€èµµæ²¡æœ‰æåˆ°çš„å†…å®¹ï¼ˆåŒ…æ‹¬æœ€åä¸€é›†åŠ¨åˆ€çš„äº‹æƒ…ï¼‰æ‰€ä»¥å„ä½å†ç­‰ç­‰å§ï¼ˆï¼‰#å›´æ£‹#å›´...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogoi2j2uo/">
    
    
    
    
    
      
    
    å› ä¸ºæˆ‘æ˜¯å…è´¹ä¼šå‘˜ï¼Œçœ‹ä¸åˆ°è€èµµè¿è½½çš„æœ€æ–°å†…å®¹ï¼Œä¸è¿‡å¬è¯´è¿™ç¯‡è¿è½½é‡Œé¢æœ‰æåˆ°å¾ˆå¤šä¹‹å‰è€èµµæ²¡æœ‰æåˆ°çš„å†…å®¹ï¼ˆåŒ…æ‹¬æœ€åä¸€é›†åŠ¨åˆ€çš„äº‹æƒ…ï¼‰<!-- raw HTML omitted --><!-- raw HTML omitted -->æ‰€ä»¥å„ä½å†ç­‰ç­‰å§ï¼ˆï¼‰<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_defaul">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_defaul</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgQjd2Pvx">æ˜¯æ—¶å€™è¦è¯·è™ä¸¸åƒå’Œåºœæé¢äº†#å›´æ£‹#å›´æ£‹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogqjd2pvx/">
    
    
    
    
    
      
    
    æ˜¯æ—¶å€™è¦è¯·è™ä¸¸åƒå’Œåºœæé¢äº†<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgQw25cRl">å¾—ï¼Œä¸ç”¨è¯·äº† - è½¬å‘ @æ‰¾å€Ÿå£å®‰é™:&amp;ensp;æ˜¯æ—¶å€™è¦è¯·è™ä¸¸åƒå’Œåºœæé¢äº†#å›´æ£‹#å›´æ£‹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogqw25crl/">
    
    
    
    
    
      
    
    å¾—ï¼Œä¸ç”¨è¯·äº†<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@æ‰¾å€Ÿå£å®‰é™<!-- raw HTML omitted -->:â€‚æ˜¯æ—¶å€™è¦è¯·è™ä¸¸åƒå’Œåºœæé¢äº†<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png%22">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgRvSosEl">æœ‰æœ‹å‹é—®æˆ‘ï¼Œæ—¥æœ¬æ£‹é™¢é¢å‘çš„è¯ä¹¦ï¼Œæ®µä½æ˜¯ä¸æ˜¯èŒä¸šæ£‹æ‰‹å’Œä¸šä½™æ£‹æ‰‹åŒæ¬¾ã€‚ç­”æ¡ˆï¼šä¸æ˜¯ã€‚åŒºåˆ«ï¼šä¸šä½™æ£‹æ‰‹å’ŒèŒä¸šæ£‹æ‰‹ï¼Œæœ€å¤§çš„åŒºåˆ«å°±æ˜¯ï¼ŒèŒä¸šæ£‹æ‰‹åœ¨åå­—å‰é¢æœ‰â€œæ£‹å£«â€ï¼Œ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogrvsosel/">
    
    
    
    
    
      
    
    æœ‰æœ‹å‹é—®æˆ‘ï¼Œæ—¥æœ¬æ£‹é™¢é¢å‘çš„è¯ä¹¦ï¼Œæ®µä½æ˜¯ä¸æ˜¯èŒä¸šæ£‹æ‰‹å’Œä¸šä½™æ£‹æ‰‹åŒæ¬¾ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ç­”æ¡ˆï¼šä¸æ˜¯ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->åŒºåˆ«ï¼šä¸šä½™æ£‹æ‰‹å’ŒèŒä¸šæ£‹æ‰‹ï¼Œæœ€å¤§çš„åŒºåˆ«å°±æ˜¯ï¼ŒèŒä¸šæ£‹æ‰‹åœ¨åå­—å‰é¢æœ‰â€œæ£‹å£«â€ï¼Œä¸šä½™æ²¡æœ‰ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_car">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_car</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgS5BnSH8">æˆ‘è§‰å¾—å¾ˆå¤šäººçœ‹ä¸èµ·æ—¥æœ¬æ£‹é™¢ï¼Œå·²ç»åˆ°äº†éšä¾¿æ‹¿ä¸€å¼ æ—¥æœ¬æ£‹é™¢é¢å‘çš„ä¸šä½™è¯ä¹¦å°±å½“æ˜¯èŒä¸šäº†ä»¥ä¸‹æ˜¯æ—¥æœ¬æ£‹é™¢å®˜ç½‘ï¼Œè¯·æŸ¥æ”¶ç½‘é¡µé“¾æ¥#å›´æ£‹#å›´æ£‹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogs5bnsh8/">
    
    
    
    
    
      
    
    æˆ‘è§‰å¾—å¾ˆå¤šäººçœ‹ä¸èµ·æ—¥æœ¬æ£‹é™¢ï¼Œå·²ç»åˆ°äº†éšä¾¿æ‹¿ä¸€å¼ æ—¥æœ¬æ£‹é™¢é¢å‘çš„ä¸šä½™è¯ä¹¦å°±å½“æ˜¯èŒä¸šäº†<!-- raw HTML omitted --><!-- raw HTML omitted -->ä»¥ä¸‹æ˜¯æ—¥æœ¬æ£‹é™¢å®˜ç½‘ï¼Œè¯·æŸ¥æ”¶<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½‘é¡µé“¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/p/index?extparam">https://m.weibo.cn/p/index?extparam</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgSVShZtj">å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šä¸€åŠ›è¾½æœ¬å› åŠæˆ˜è¾¾æˆè¿éœ¸ï¼Œä½™æ­£éº’æ— åŠ›å›å¤©ã€‹ #å›´æ£‹# å›´æ£‹ ä¸€åŠ›è¾½æœ¬å› åŠæˆ˜è¾¾æˆè¿éœ¸ï¼Œä½™æ­£éº’æ— åŠ›å›å¤© [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogsvshztj/">
    
    
    
    
    
      
    
    å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šä¸€åŠ›è¾½æœ¬å› åŠæˆ˜è¾¾æˆè¿éœ¸ï¼Œä½™æ­£éº’æ— åŠ›å›å¤©ã€‹ <!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgNBp43zs">ä¹…ä¿å²ç»ªé‡Œvia.å²¡ç”°å‡†ä¸€ Xä¿¡é•¿æ—¶ä»£çš„å¥³å„¿ä¹…ä¿å²ç»ªé‡Œæ¡‘çš„è„¸é¢Šè½¯ä¹ä¹çš„ï¼Œå¾ˆéš¾ä¸‹å¾—äº†æ‰‹å»çŒ›æŠ“ã€‚å› ä¸ºå½“æ—¶æ˜¯çªç„¶è¿™æ ·åšçš„æ‰€ä»¥è¿˜ä»¥ä¸ºä¼šè¢«å¥¹è®¨åŒï¼Œä½†å†ä¼šçš„é‚£å¤©å¥¹è¿˜æ˜¯ä¸€...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ognbp43zs/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.å²¡ç”°å‡†ä¸€ X<!-- raw HTML omitted -->ä¿¡é•¿æ—¶ä»£çš„å¥³å„¿<!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œæ¡‘çš„è„¸é¢Šè½¯ä¹ä¹çš„ï¼Œå¾ˆéš¾ä¸‹å¾—äº†æ‰‹å»çŒ›æŠ“ã€‚<!-- raw HTML omitted -->å› ä¸ºå½“æ—¶æ˜¯çªç„¶è¿™æ ·åšçš„æ‰€ä»¥è¿˜ä»¥ä¸ºä¼šè¢«å¥¹è®¨åŒï¼Œä½†å†ä¼šçš„é‚£å¤©å¥¹è¿˜æ˜¯ä¸€å¤§æ—©å°±å«æˆ‘ã€Œçˆ¶äº²ï¼ã€ã€‚<!-- raw HTML omitted -->æ²¡è¢«å¥¹è®¨åŒçœŸçš„å¤ª &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgO4mClAf">ä¹…ä¿å²ç»ªé‡Œéº¦å½“åŠ³ã€Œã‚¹ãƒ‘ã‚¤ã‚·ãƒ¼ãƒã‚­ãƒ³ãƒãƒƒã‚¯ãƒŠã‚²ãƒƒãƒˆï¼ˆéº¦è¾£é¸¡å—ï¼‰ã€æ–°CMğŸ”ğŸŸ çŸ­ç‰ˆ é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogo4mclaf/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->éº¦å½“åŠ³ã€Œã‚¹ãƒ‘ã‚¤ã‚·ãƒ¼ãƒã‚­ãƒ³ãƒãƒƒã‚¯ãƒŠã‚²ãƒƒãƒˆï¼ˆéº¦è¾£é¸¡å—ï¼‰ã€æ–°CMğŸ”ğŸŸ çŸ­ç‰ˆ <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgR29jVMX">æ›´æ–°äº†tag - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#shiorigram# .#ä¹ƒæœ¨å‚46ANN##è¯¦æƒ…è¯·å¬å¬å¹¿æ’­##å¤§å®¶çš„è¦æ±‚å¾ˆä¸¥æ ¼##è¡£è¢–åˆæŠ˜èµ·æ¥äº†##å¤§å®¶éƒ½æ¸©æŸ”ä¸€ç‚¹å§# .#ä¹ƒæœ¨å‚46...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogr29jvmx/">
    
    
    
    
    
      
    
    æ›´æ–°äº†tag<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extpara">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extpara</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgR2ngysH">ä¹…ä¿å²ç»ªé‡Œ#shiorigram##ä¹ƒæœ¨å‚46ANN##é€šçŸ¥å„ä½å¬ä¼—##æˆ‘çœŸçš„åŠ tagäº†å“¦#è¯¦æƒ…è¯·å¬å¬è¿™å‘¨çš„å¹¿æ’­å“¦ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogr2ngysh/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgRYjzkMf">ä¹…ä¿å²ç»ªé‡Œä¹ƒæœ¨æ‹æ–°å¡ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogryjzkmf/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ƒæœ¨æ‹æ–°å¡ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1hq90won1ouj30h">https://tvax3.sinaimg.cn/large/006z6nxLgy1hq90won1ouj30h</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1cZ421s7e8">é™ˆç¿”å…­ç‚¹åŠï¼šå“ªä¸ªç”·å‹ç»ä¸èµ·è¿™æ ·çš„è€ƒéªŒ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1cz421s7e8/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1Ry411875K">ä»â€œå’Œè€Œä¸åŒâ€åˆ°â€œç‹¬ç«‹è‡ªä¸»â€ï¼šäºšæ´²æ™ºæ…§çš„ç‹¬ç‰¹é­…åŠ›ã€è¿™å°±æ˜¯ä¸­å›½ã€‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1ry411875k/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/364392686/answer/3511392176">ä¹Œé¸¦æ ¡å°‰èµåŒäº†å›ç­”: ã€Šåº†ä½™å¹´ã€‹å°è¯´æœ€åçš„ç»“å±€æ˜¯ä»€ä¹ˆï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-364392686-answer-3511392176/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/370967275/answer/3516212266">å¼ æ•¬ä¿¡å›ç­”äº†é—®é¢˜: åˆ©ç”¨pythonå¦‚ä½•å°†å¤šä¸ªExcelæ–‡ä»¶åˆå¹¶åˆ°ä¸€ä¸ªexcelä¸­ï¼Œsheetå‘½åä¸ºexcelçš„åå­—ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-370967275-answer-3516212266/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/522856095/answer/3515848796">ä¹Œé¸¦æ ¡å°‰èµåŒäº†å›ç­”: ä½ æœ€æ„å¤–çš„ä¸€ç¬”æ”¶å…¥æ˜¯ä»€ä¹ˆï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-522856095-answer-3515848796/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/657591428/answer/3515246177">ä¹Œé¸¦æ ¡å°‰èµåŒäº†å›ç­”: å¦‚ä½•çœ‹å¾…ç½‘ä¼ æ–¯å¦ç¦å¤§å­¦æ¯•ä¸šç”Ÿä¸Šå²¸çš–åŒ—ä¹¡é•‡å…¬åŠ¡å‘˜ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-657591428-answer-3515246177/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/657649755/answer/3515369239">ä¹Œé¸¦æ ¡å°‰èµåŒäº†å›ç­”: å°±å¹³å‡ä¸ªä½“è€Œè¨€ï¼Œå†œè€•æ°‘æ—çš„å¹³å‡æˆ˜æ–—åŠ›å’Œæ¸¸ç‰§æ°‘æ—çš„å¹³å‡æˆ˜æ–—åŠ›å“ªä¸ªå¼ºï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-657649755-answer-3515369239/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/657656571/answer/3515707776">ä¹Œé¸¦æ ¡å°‰èµåŒäº†å›ç­”: å¤–äº¤éƒ¨ç§°ã€Œå¦‚æœæ¬§æ–¹ä¸€æ„å­¤è¡Œï¼Œä¸­æ–¹ç»ä¸ä¼šåè§†ä¸ç®¡ï¼Œå°†é‡‡å–ä¸€åˆ‡å¿…è¦æªæ–½ã€ï¼Œå“ªäº›ä¿¡æ¯å€¼å¾—å…³æ³¨ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-657656571-answer-3515707776/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/657735875/answer/3515840523">ä¹Œé¸¦æ ¡å°‰èµåŒäº†å›ç­”: 34 é¡¹é‡ç½ªæŒ‡æ§æˆç«‹ï¼Œç‰¹æœ—æ™®æˆç¾å›½å²ä¸Šé¦–ä½è¢«åˆ¤æœ‰ç½ªçš„å‰æ€»ç»Ÿï¼Œè¿™æ„å‘³ç€ä»€ä¹ˆï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-657735875-answer-3515840523/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700894235">é‡å­ä½å‘è¡¨äº†æ–‡ç« : æ˜Ÿç¯ç§‘æŠ€é‡ç£…å‘å¸ƒçŸ¥è¯†å¹³å°TKHï¼ŒåŠ©åŠ›ä¼ä¸šæ‰“é€ å¯ä¿¡èµ–çš„AI Infra</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700894235/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700894964">é‡å­ä½å‘è¡¨äº†æ–‡ç« : OpenAIè¢«æ›å¸®è‹¹æœSiriæ¢è„‘ï¼Œå¾®è½¯æ€¥äº†ï¼šCEOçº¦è°ˆå¥¥ç‰¹æ›¼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700894964/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700896387">é‡å­ä½å‘è¡¨äº†æ–‡ç« : è¿™å®¶äº§å“AIç”¨æˆ·è¿‡äº¿ï¼Œæœˆæ´»ç¬¬ä¸€ï¼Œè¦†ç›–å­¦ä¹ åŠå…¬æ•™è‚²ï¼Œæœ‰äººç”¨æ¥èµšé’±</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700896387/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700901391">é‡å­ä½å‘è¡¨äº†æ–‡ç« : AIåœ¨å’³å—½ä¸­æ£€å‡ºç™Œç—‡ï¼Œä¸ä¿¡ï¼Ÿä¸–å«ç»„ç»‡æ­£å…¨çƒæ¨å¹¿</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700901391/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700903325">é‡å­ä½å‘è¡¨äº†æ–‡ç« : 1/3å¹´è½»äººæ„¿å’ŒAIäº¤æœ‹å‹ï¼Œè¶…1æˆå¹´è½»äººå·²ç»é AIGCèµšè¿‡é’±äº†ï½œSoul AppæŠ¥å‘Šåˆ†äº«</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700903325/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700914231">é‡å­ä½å‘è¡¨äº†æ–‡ç« : æ¸…åâ€œå¤©çœ¸èŠ¯â€ç™»Natureå°é¢ï¼å…¨çƒé¦–æ¬¾ç±»è„‘äº’è¡¥è§†è§‰èŠ¯ç‰‡ï¼Œæ–½è·¯å¹³å›¢é˜Ÿæœ€æ–°æˆæœ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700914231/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701021169">é‡å­ä½å‘è¡¨äº†æ–‡ç« : æ— éœ€3Dæ•°æ®ä¹Ÿèƒ½è®­ç»ƒï¼Œæ¸¯ç§‘&amp;æ¸¯ä¸­æ–‡è”æ‰‹åä¸ºæ¨å‡º3Dè‡ªåŠ¨é©¾é©¶åœºæ™¯ç”Ÿæˆæ¨¡å‹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701021169/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

